alliqua biomedical inc k jan    pm  seeking alphasign in  join nowgo»alliqua biomedical inc alqaform k  current reportjan    pmabout alliqua biomedical inc alqaview as pdf alliqua biomedical inc form k received     united states securities and exchange commission washington dc        form k   current report pursuant to section  or d of the securities exchange act of        date of report date of earliest event reported january     alliqua biomedical inc exact name of registrant as specified in its charter   delaware       state or other jurisdiction of incorporation   commission file number   irs employer identification no    stony hill road suite  yardley pa     address of principal executive offices   zip code   registrant’s telephone number including area code     former name or former address if changed since last report       check the appropriate box below if the form k filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions   x written communications pursuant to rule  under the securities act  cfr    ¨ soliciting material pursuant to rule a under the exchange act  cfr a   ¨ precommencement communications pursuant to rule db under the exchange act  cfr db   ¨ precommencement communications pursuant to rule e c under the exchange act  cfr ec              item  entry into a material definitive agreement   on january   alliqua biomedical inc the “ company ” aquamed technologies inc a wholly owned subsidiary of the company the “ guarantor ” and perceptive credit holdings lp “ perceptive ” entered into a forbearance and amendment agreement the “ amendment agreement ” pursuant to which the parties agreed to certain amendments and modifications to the terms of the credit agreement and guaranty dated may   by and among the company the guarantor and perceptive the “ credit agreement ” the amendment agreement provides for among other things an extension to the currently effective forbearance period in respect of the company’s default of a covenant pertaining to trailing twelvemonth revenue under the credit agreement as of both september   and december   the “ specified defaults ” under the amendment agreement perceptive has agreed to forbear from exercising any rights and remedies related to the specified defaults until the earlier of i march   ii the date when perceptive becomes aware that any other default other than the specified defaults has occurred and is continuing and iii the date on which perceptive becomes aware that the previously announced contribution agreement and plan of merger dated october   the “ contribution and merger agreement ” by and among the company alliqua holdings inc “ parent ” chesapeake merger corp and soluble systems llc “ soluble ” has been terminated and the transactions contemplated thereby the “ transactions ” will not be consummated such earlier date the “ termination date ” perceptive reserved the right commencing on the termination date to pursue any rights and remedies available to it under the credit agreement with respect to either or both of the specified defaults   in addition the amendment agreement grants a onetime waiver of certain restrictive covenants under the credit agreement in order to allow the company to lend  to soluble in order to extend the outside date of the contribution and merger agreement to february   the amendment agreement also requires the company to certify its compliance with certain existing covenants under the credit agreement that require the company and its subsidiaries to maintain a weekly minimum balance of  in unrestricted unencumbered cash on a weekly basis   in connection with the entry into the amendment agreement the company and perceptive also entered into an amendment and restatement of the warrant issued to perceptive in connection with the closing of the credit agreement on may   the amended and restated warrant the “ amended warrant ” is exercisable for  shares of the company’s common stock par value  per share the “ common stock ” at an exercise price of  the “ exercise price ” provided that i if the transactions occur on or before march   the exercise price will be automatically adjusted to an amount per share equal to the per share value of the common stock or equivalent of the company or parent immediately after giving effect to the consummation of the transactions and ii in the event the transactions do not occur on or before march   but an eligible equity financing for gross proceeds of at least  million occurs on or before such date the exercise price will automatically adjust to be an amount per share equal to the per share value of the common stock or equivalent issued to nonaffiliates pursuant to such eligible equity financing   the foregoing descriptions of the amendment agreement and the amended warrant do not purport to be complete and are qualified in their entirety by reference to the full text of the amendment agreement and the amended warrant copies of which are attached hereto as exhibit  and exhibit  respectively and incorporated herein by reference             item  creation of a direct financial obligation or an obligation under an offbalance sheet arrangement of a registrant   the information set forth under item  of this current report on form k is hereby incorporated by reference into this item    item  unregistered sales of equity securities   the information regarding the issuance of the amended warrant to perceptive set forth under item  of this current report on form k is incorporated herein by reference the amended warrant offered and issued to perceptive was not registered under the securities act of  as amended the “ securities act ” or the securities laws of any state and was issued in reliance on the exemption from registration under the securities act provided by section a and regulation d rule  under the securities act perceptive represented that it was an accredited investor as defined by rule  under the securities act   item  other events   on january   the company elected to extend the outside date of the contribution and merger agreement and advanced  to soluble in accordance with the terms of the contribution and merger agreement   item  financial statements and exhibits   d exhibits   exhibit number   description    forbearance and amendment agreement dated january   by and among alliqua biomedical inc aquamed technologies inc and perceptive credit holdings lp    amended warrant dated january   by and between alliqua biomedical inc and perceptive credit holdings lp             signatures   pursuant to the requirements of the securities exchange act of  the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized     alliqua biomedical inc       dated january   by s brian posner     name brian posner     title chief financial officer             exhibit    forbearance and amendment agreement   this forbearance and amendment agreement dated as of january   this “ agreement ” is made by and among alliqua biomedical inc a delaware corporation the “ borrower ” a quamed technologies  inc a delaware corporation the “ guarantor ” the borrower and the guarantor are each also referred to herein individually as an “ obligor ” and collectively as the “ obligors ” and perceptive credit holdings lp a delaware limited partnership the “ lender ” unless otherwise defined herein or the context otherwise requires terms used in this agreement including its preamble and recitals have the meanings provided in the credit agreement defined below   witnesseth    whereas the borrower the guarantor and the lender are parties to that certain credit agreement and guaranty dated as of may   the “ credit agreement ”   whereas pursuant to section b of the credit agreement a consolidated total revenue of the borrower for the twelve consecutive month period ended september   was required to be  and b consolidated total revenue of the borrower for the twelve consecutive month period ended december   was required to be    whereas the borrower has requested that the lender agree to certain amendments and modifications to the credit agreement as further described herein and   whereas the lender is willing to agree to such amendments and modifications subject to the terms and conditions set forth herein   now therefore in consideration of the mutual agreements provisions and covenants contained herein the parties agree as follows   article i definitions   section       certain terms  the following terms whether or not highlighted in bold andor italics when used in this agreement including its preamble and recitals shall have the following meanings such definitions to be equally applicable to the singular and plural forms thereof   “ agreement ” is defined in the preamble    “ borrower ” is defined in the preamble    “ chesapeake contribution and merger agreement ” means collectively that certain contribution agreement and plan of merger dated as of october   as subsequently amended or otherwise modified among the company alliqua holdings inc a wholly owned subsidiary of the company “ new alliqua ” chesapeake merger corp a wholly owned subsidiary of alliqua holdings inc “ chesapeake merger corp ” and soluble systems llc and all exhibits addendums and other ancillary documents and instruments relative thereto or all or any portion of the chesapeake transaction            “ chesapeake merger corp ” has the meaning provided within the definition of “chesapeake contribution and merger agreement”   “ chesapeake transaction ” means the transactions contemplated pursuant to the chesapeake contribution and merger agreement including i the proposed reorganization resulting from the merger of chesapeake merger corp with and into the borrower ii the conversion of the borrower’s common stock into common stock par value  per share of new alliqua and iii the contribution by soluble systems llc of substantially all of its assets to the surviving corporation of the above referenced merger   “ credit agreement ” is defined in first recital    “ forbearance and amendment effective date ” is defined in article iv    “ guarantor ” is defined in the preamble    “ lender ” is defined in the preamble    “ new alliqua ” has the meaning provided within the definition of “chesapeake contribution and merger agreement”   “ obligor ” is defined in the preamble    “ specified defaults ” is defined in section a    “ termination date ” is defined in section b    article ii forbearance etc   section       forbearance etc    a          the borrower acknowledges and agrees that it was in default of section b of the credit agreement as of both september   and december   such defaults being herein referred to as the “ specified defaults ” the lender hereby agrees that with respect to the specified defaults but only the specified defaults it will refrain and forebear from exercising or pursuing any rights or remedies under the credit agreement or otherwise including imposing a default rate of interest in respect of the specified defaults pursuant to section  of the credit agreement or any other loan document until but only until the termination date any term or provision hereof to the contrary notwithstanding the lender is not waiving any of its rights or remedies with respect to the specified defaults or any other default but instead is simply agreeing not to take remedial action with respect to the specified defaults until the termination date            b       the “ termination date ” shall mean the earlier of i march   ii the date when the lender becomes aware that any other default other than any specified default has occurred and is continuing and iii the date on which the lender becomes aware that the chesapeake transaction will not be consummated and the chesapeake contribution and merger agreement has been terminated upon the occurrence of the termination date the lender may with respect to either or both of the specified defaults pursue any rights and remedies available to it under the credit agreement or any other loan document or pursuant to law or otherwise with respect to any defaults that have then occurred and are outstanding including the specified defaults including but not limited to declaring all or any portion of the outstanding principal amount of the loan and other obligations to be immediately due and payable imposing a default rate of interest in respect of the obligations in accordance with section  of the credit agreement or pursuing any or all other rights and remedies of the lender as a secured party under the ucc the pledge and security agreement or any other loan document   c       the company shall not enter into any amendment or otherwise modify the chesapeake contribution and merger agreement or waive any term provision or condition relative thereto or to all or any portion of the chesapeake transaction in each case in a manner that is materially adverse to the interests of the lender without the prior written consent of the lender in addition as a condition precedent to consummating the chesapeake transaction or any portion thereof in the event the company’s common stock is or is to be converted into common stock of new alliqua prior to or simultaneously with the consummation of such conversion an amended and replacement warrant shall have been issued by new alliqua to the lender or its designee or assign that among other things reflects such conversion and otherwise contains terms and provisions reasonably satisfactory to the lender   section    limited waiver  lender hereby grants the borrower a onetime waiver of section  of the credit agreement in order to allow the borrower to lend  to soluble systems llc in order to extend the outside date as defined in the chesapeake contribution and merger agreement until february   in accordance with section diii of the chesapeake contribution and merger agreement for the avoidance of doubt nothing herein shall be construed as a continuing waiver of section  or any other provision of the loan documents   article iii amendments to credit agreement   the provisions of the credit agreement referred to below are hereby amended in accordance with this article iii   except as expressly so amended the parties hereto expressly acknowledge and agree that all other terms and provisions of the credit agreement and each other loan document shall continue in full force and effect without amendment or other modification of any type            section      amendment to section a  effective on and subject to the occurrence of the forbearance and amendment effective date section a of the credit agreement is hereby amended and restated in its entirety as follows   “a       the loan parties on a consolidated basis shall maintain at all times a minimum balance of  in unrestricted unencumbered cash in one or more controlled accounts that is free and clear of all liens other than liens granted hereunder in favor of the lender and permitted liens no later than three  business days following the end of each calendar week the borrower shall deliver to the lender a written statement certified by an authorized officer of the borrower which evidences in reasonable detail the amount of unrestricted unencumbered cash held in such controlled accounts as of the end of the previous calendar week”   article iv conditions precedent   this agreement shall become effective upon and shall be subject to the prior or simultaneous satisfaction of each of the following conditions in a manner reasonably satisfactory to the lender the date when all such conditions are so satisfied being the “ forbearance and amendment effective date ”   section       amended and restated warrant  the lender shall have received an amended warrant in the form of exhibit a hereto fully executed by the borrower   section       chesapeake contribution and merger agreement  the lender shall have received a true and correct copy of the chesapeake contribution and merger agreement and such other documents and instruments specified in section  below   section       counterparts  the lender shall have received counterparts of this agreement executed on behalf of the borrowers the guarantor and the lender   section       effective date certificate  the lender shall have received a certificate dated as of the forbearance and amendment effective date and duly executed and delivered by an authorized officer of the borrower and each guarantor certifying as to the matters set forth in articles v and vi hereof in form and substance satisfactory to the lender   section       costs and expenses etc  the lender shall have received all fees costs and expenses due and payable pursuant to section  of the credit agreement including without limitation the reasonable fees and expenses of morrison  foerster llp counsel to the lender if then invoiced together with any other fees separately agreed to by the borrower and the lender such fees costs and expenses not to exceed  in the aggregate   section       satisfactory legal form etc  all legal matters incident to the effectiveness of this agreement shall be reasonably satisfactory to the lender and its counsel   article v representations and warranties   to induce the lender to enter into this agreement each obligor represents and warrants to the lender as set forth below            section       validity etc  this agreement and the credit agreement after giving effect to this agreement each constitutes the legal valid and binding obligation of each obligor enforceable in accordance with its respective terms subject to the effects of bankruptcy insolvency fraudulent conveyance reorganization moratorium and other similar laws relating to or affecting creditors’ rights generally general equitable principles whether considered in a proceeding in equity or at law and an implied covenant of good faith and fair dealing   section       representations and warranties etc  immediately prior to and immediately after giving effect to this agreement the following statements shall be true and correct   a            the representations and warranties set forth in each loan document as defined in the credit agreement shall in each case be in the case of representations and warranties qualified as to knowledge materiality material adverse effect as defined in the credit agreement or any similar qualification true and correct in all respects and in the case of those representations and warranties that are not so qualified in all material respects with the same effect as if then made unless stated to relate solely to an earlier date in which case such representations and warranties shall be true and correct in all material respects as of such earlier date and   b            no default other than the specified defaults shall have then occurred and be continuing   section       chesapeake contribution and merger agreement  attached as exhibit b hereto is a true and correct copy of the chesapeake contribution and merger agreement together with all exhibits and attachments thereto and all amendments waivers and other modifications thereto since october     article vi confirmation   section       reaffirmation  each obligor hereby consents to the modifications made to the loan documents pursuant to this agreement and hereby agrees that after giving effect to this agreement each loan document to which it is a party and all obligations thereunder including the guarantees made pursuant to article x of the credit agreement are and shall continue to be in full force and effect and the same are hereby ratified in all respects except that upon the occurrence of the forbearance and amendment effective date all references in such loan documents to the “credit agreement” “loan documents” “thereunder” “thereof” or words of similar import shall mean the credit agreement and the other loan documents as amended or otherwise modified by this agreement   section       validity etc  each obligor hereby represents and warrants as of the forbearance and amendment effective date that immediately after giving effect to this agreement each loan document in each case as modified by this agreement where applicable and whether directly or indirectly to which it is a party continues to be a legal valid and binding obligation of such obligor enforceable against such person in accordance with its terms subject to the effects of bankruptcy insolvency fraudulent conveyance reorganization moratorium and other similar laws relating to or affecting creditors’ rights generally general equitable principles whether considered in a proceeding in equity or at law and an implied covenant of good faith and fair dealing            article vii miscellaneous   section       no waiver  the lender’s agreement not to pursue its rights and remedies until the occurrence of the termination date as described in section  herein is temporary and limited in nature except as expressly provided herein i nothing contained herein shall be deemed to constitute a waiver of the specified defaults or any other default or event of default or compliance with any term or condition contained in the credit agreement or any of the other loan documents or constitute a course of conduct or dealing among the parties and ii the lender reserves all rights privileges and remedies under the credit agreement and the other loan documents   section       severability  in case any provision of or obligation under this agreement shall be invalid illegal or unenforceable in any jurisdiction the validity legality and enforceability of the remaining provisions or obligations or of such provision or obligation in any other jurisdiction shall not in any way be affected or impaired thereby   section       integration  this agreement together with the other loan documents incorporates all negotiations of the parties hereto with respect to the subject matter hereof and is the final expression and agreement of the parties hereto with respect to the subject matter hereof   section       crossreferences headings  references in this agreement to any article or section are unless otherwise specified to such article or section of this agreement headings and captions used in this agreement are included for convenience of reference only and shall not be given any substantive effect   section       loan document pursuant to credit agreement  this agreement is a loan document executed pursuant to the credit agreement and shall unless otherwise expressly indicated therein be construed administered and applied in accordance with all of the terms and provisions of the credit agreement as amended hereby including article xi thereof and all rules of interpretation set forth in article i thereof   section       successors and assigns  this agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and permitted assigns   section       counterparts  this agreement may be executed in any number of counterparts all of which taken together shall constitute one and the same instrument and any of the parties hereto may execute this agreement by signing any such counterpart  delivery of an executed counterpart of a signature page to this agreement by facsimile or other electronic transmission shall be effective as delivery of a manually executed counterpart of this agreement            section       governing law  this agreement shall be governed by and construed in accordance with the internal laws of the state of new york without regard to principles of conflicts of laws that would result in the application of the laws of any other jurisdiction provided that section  of the new york general obligations law shall apply   section       full force and effect limited amendment  except as expressly amended hereby the obligors each jointly and severally agree that all of the representations warranties terms covenants conditions and other provisions of the credit agreement and the other loan documents shall remain unmodified and shall continue to be and shall remain in full force and effect in all respects  the amendments and other waivers and modifications set forth in this agreement shall be limited precisely as provided for herein to the provisions expressly amended herein or otherwise modified or waived hereby and shall not be deemed to be an amendment to waiver of consent to or modification of any other term or provision of the credit agreement or any other loan document or of any transaction or further or future action on the part of any loan party which would require the consent of the lender under the credit agreement or any of the loan documents   signature pages to follow            in witness whereof the parties hereto have caused this agreement to be duly executed and delivered as of the day and year first above written     borrower       alliqua biomedical inc         by s brian m posner   name brian m posner   title cfo       guarantor       aquamed technologies inc         by s brian m posner   name brian m posner   title cfo            lender       perceptive credit holdings lp       by perceptive credit opportunities gp llc   its general partner         by s sandeep dixit     sandeep dixit     chief credit officer         by s sam chaula   name sam chaula   title portfolio manager              exhibit    amended warrant   this amended warrant and the securities issuable upon exercise of this warrant as further amended or otherwise modified this “ warrant ” have not been registered under the securities act of  as amended the “ act ” or qualified under any state or foreign securities laws and may not be offered for sale sold pledged hypothecated or otherwise transferred or assigned unless i a registration statement covering such shares is effective under the act and is qualified under applicable state and foreign law or ii the transaction is exempt from the registration and prospectus delivery requirements under the act and the qualification requirements under applicable state and foreign law and if the company requests an opinion satisfactory to the company to such effect has been rendered by counsel   warrant certificate no    second amendment date january   first amendment date october   issue date may     for value received alliqua biomedical inc a delaware corporation the “ company ” hereby certifies that perceptive credit holdings lp the “ initial holder ” as the assignee of perceptive credit opportunities fund lp is entitled to purchase from the company  duly authorized validly issued fully paid and nonassessable shares of common stock at a purchase price per share equal to the exercise price defined below all subject to the terms conditions and adjustments set forth below certain capitalized terms used herein are defined in section  hereof   whereas this warrant was originally issued as so originally issued the “ initial warrant ” pursuant to the terms of and as a condition precedent to the making of the loan under the credit agreement and guaranty dated as of may   as subsequently amended or otherwise modified the “ credit agreement ” among the company perceptive credit holdings lp and the guarantors parties thereto   whereas in connection with and as a condition precedent to the effectiveness of certain amendments and other modifications to the credit agreement on or about october   the initial warrant was amended and otherwise modified in its entirety as so amended and modified the “ first amended warrant ” and together with the initial warrant the “ old warrant ” as of such date the “ first amendment date ” and            whereas in connection with and as a condition precedent to the effectiveness of the further amendment and other modification of the credit agreement as of january   the old warrant is hereby further amended and otherwise modified in its entirety to read as set forth herein as of such date the “ second amendment date ”   now therefore the company and the initial holder each hereby agrees that upon‎ execution and delivery of this warrant ‎the old warrant shall be amended and restated in its entirety to read as set forth herein   section               definitions  as used herein capitalized terms have the meanings set forth below   a           certain terms  the following terms will have the following meanings when used herein   “ aggregate exercise price ” means an amount equal to the product of i the number of warrant shares in respect of which this warrant is then being exercised pursuant to section  hereof multiplied by ii the exercise price in effect as of the exercise date in accordance with the terms hereof   “ board ” means the board of directors or equivalent of the company   “ business day ” means any day except a saturday sunday or legal holiday on which banking institutions in new york city are authorized or obligated by law or executive order to close   “ cash payment ” has the meaning set forth in section bi    “ choice acquisition agreement ” means that certain agreement and plan of merger dated may   by and among the company alqa merger sub inc and choice therapeutics inc   “ chesapeake contribution and merger agreement ” means that certain contribution agreement and plan of merger dated as of october   as subsequently amended or otherwise modified among the company alliqua holdings inc a wholly owned subsidiary of the company “ new alliqua ” chesapeake merger corp a wholly owned subsidiary of alliqua holdings inc“ chesapeake merger corp ” and soluble systems llc   “ chesapeake merger corp ” has the meaning provided within the definition of “chesapeake contribution and merger agreement”            “ chesapeake transaction ” means the transactions contemplated pursuant to the chesapeake contribution and merger agreement including i the proposed reorganization of the company resulting from the merger of chesapeake merger corp with and into the company ii the conversion of the company’s common stock into common stock par value  per share of new alliqua and iii the contribution by soluble systems llc of substantially all of its assets to the surviving corporation of the above referenced merger   “ common stock ” means the common stock par value  per share of the company and any capital stock into which such common stock shall have been converted exchanged or reclassified following the date hereof   “ common stock deemed outstanding ” means at any given time the sum of i the number of shares of common stock actually outstanding at such time plus ii the number of shares of common stock issuable upon exercise of options actually outstanding at such time plus iii the number of shares of common stock issuable upon conversion or exchange of convertible securities actually outstanding at such time treating as actually outstanding any convertible securities issuable upon exercise of options actually outstanding at such time in each case regardless of whether the options or convertible securities are actually exercisable at such time   “ company ” has the meaning set forth in the preamble   “ convertible securities ” means any securities directly or indirectly convertible into or exchangeable for common stock but excluding options   “ credit agreement ” has the meaning set forth in the recitals   “ demand registration ” has the meaning set forth in the registration rights addendum   “ eligible equity sale ” means the sale by either the company or new alliqua or any of their respective successors of its common stock or equivalent whether pursuant to a public offering private placement or otherwise i to persons that are not affiliates of the company or new alliqua and ii that results in gross sale proceeds to the company or new alliqua of at least             “ excluded issuances ” means any issuance or sale or deemed issuance or sale in accordance with section d by the company after the issue date of i shares of common stock issued upon the exercise of the warrant ii shares of common stock as such number of shares is equitably adjusted for subsequent stock splits stock combinations stock dividends and recapitalizations issued directly or upon the exercise of options to employees officers or directors of the company pursuant to any stock or option plan duly adopted for such purpose by a majority of the board and the affirmative vote of the requisite number of the company’s stockholders subject to adjustment for reverse and forward stock splits and similar transactions iii shares of common stock issuable upon exercise conversion or exchange of options or convertible securities issued and outstanding on february   provided that such options or convertible securities have not been amended since the date of this warrant to increase the number of shares of common stock or to decrease the exercise price exchange price or conversion price of such securities iv securities issued pursuant to the merger agreement or the choice acquisition agreement and v other shares of common stock to the extent but only to the extent that x such issuance or sale occurred on or before december   and y the proceeds of such sale or issuance when taken together with all other such issuances and sales pursuant to this clause v  do not result in gross selling proceeds to the company in excess of    “ exercise date ” means for any given exercise of the warrant the date on which the conditions to such exercise as set forth in section  shall have been satisfied at or prior to  pm eastern standard time on a business day including without limitation the receipt by the company of the exercise agreement the warrant and the aggregate exercise price   “ exercise agreement ” has the meaning set forth in section ai    “ exercise period ” has the meaning set forth in section     “ exercise price ” means subject in each case to section  below an amount per share equal to  provided that ‎i if the chesapeake transaction occurs on or before march   including the proposed merger of chesapeake merger corp with and into the company the exercise price shall automatically adjust to be an amount per share equal to the per share value of the common stock or equivalent of the company or new alliqua immediately after giving effect to the consummation of the chesapeake ‎transaction and ii in the event that the chesapeake transaction does not occur on or before march   but an eligible equity sale occurs on or before such date the exercise price shall automatically adjust to be an amount per share equal to the per share value of the common stock or equivalent of the company or new alliqua issued to nonaffiliates of the company and new alliqua pursuant to such eligible equity sale any term or provision hereof to the contrary notwithstanding in the event there is an adjustment of the exercise price pursuant to the proviso above the initial holder shall determine the exercise price and shall provide written notice of such determination in reasonable detail to the company and new alliqua which determination shall be binding on all parties hereto including new alliqua or any other successor or survivor of the company for all purposes hereof barring manifest error            “ fair market value ” means for any date the price determined by the first of the following clauses that applies i if the common stock is then listed or quoted on a trading market the daily volume weighted average price of the common stock for such date or the nearest preceding date on the trading market on which the common stock is then listed or quoted as reported by bloomberg lp or a similar quotation system or association for such day based on a trading day from  am new york city time to  pm new york city time or ii in all other cases the fair market value of a share of common stock as determined by an independent appraiser selected jointly by the initial holder and the company   “ first amended warrant ” has the meaning set forth in the recitals   “ first amendment date ” has the meaning set forth in the recitals   “ holder ” has the meaning provided in the registration rights addendum   “ initial holder ” has the meaning set forth in the preamble   “ initial warrant ” has the meaning set forth in the recitals   “ issue date ” means the date set forth as such in the preamble hereto   “ new alliqua ” has the meaning provided within the definition of “chesapeake contribution and merger agreement”   “ old warrant ” has the meaning set forth in the recitals   “ options ” means any warrants or other rights or options to subscribe for or purchase common stock or convertible securities   “ piggyback registration ” has the meaning set forth in the registration rights addendum   “ purchase rights ” has the meaning set forth in section     “ registration rights ” has the meaning set forth in section     “ registration rights addendum ” has the meaning set forth in section     “ second amendment date ” has the meaning set forth in the recitals   “ trading market ” means any of the following markets or exchanges on which the common stock is listed or quoted for trading on the date in question the nyse mkt the nasdaq capital market the nasdaq global market the nasdaq global select market the new york stock exchange the otc bulletin board or any overthecounter market operated by otc markets group inc or any successors to any of the foregoing            “ vwap ” means with respect to determining the fair market value of any common stock or equivalent as of any day the valuation method described in clause i of the definition of “fair market value”   “ warrant ” has the meaning set forth in the preamble   “ warrant register ” has the meaning set forth in section     “ warrant shares ” means the shares of common stock or other capital stock of the company then purchasable upon exercise of this warrant in accordance with the terms hereof   b           credit agreement terms  unless otherwise defined capitalized terms used herein will have the meanings ascribed thereto in the credit agreement   section              term of warrant  subject to the terms and conditions hereof at any time or from time to time after the date hereof and prior to  pm eastern standard time on the fifth anniversary of the second amendment date or if such day is not a business day on the next preceding business day the “ exercise period ” the holder of this warrant may exercise this warrant for all or any part of the warrant shares purchasable hereunder subject to adjustment as provided herein   section               exercise of warrant    a           exercise procedure  this warrant may be exercised from time to time on any business day during the exercise period for all or any part of the unexercised warrant shares upon   i          surrender of this warrant subject to section e to the company at its then principal executive offices or an indemnification undertaking with respect to this warrant in the case of its loss theft or destruction together with an exercise agreement in the form attached hereto as exhibit a each an “ exercise agreement ” duly completed including specifying the number of warrant shares to be purchased and executed and   ii         payment to the company of the aggregate exercise price in accordance with section b    b           payment of the aggregate exercise price  payment of the aggregate exercise price shall be made at the option of the holder as expressed in the exercise agreement by the following methods   i          by delivery to the company of a certified or official bank check payable to the order of the company or by wire transfer of immediately available funds to an account designated in writing by the company in either case in the amount of such aggregate exercise price collectively a “ cash payment ”            ii         by instructing the company to withhold a number of warrant shares then issuable upon exercise of this warrant with an aggregate fair market value as of the exercise date equal to such aggregate exercise price or   iii        any combination of the foregoing   provided that any term or provision of this section b to the contrary notwithstanding with respect to any exercise of this warrant not less than onehalf  of the aggregate exercise price payable as a result of such exercise shall be in the form of a cash payment in the event of any withholding of warrant shares pursuant to clause ii or iii above where the number of shares whose value is equal to the aggregate exercise price is not a whole number the number of shares withheld by the company shall be rounded up to the nearest whole share and the company shall make a cash payment to the holder by delivery of a certified or official bank check or by wire transfer of immediately available funds based on the incremental fraction of a share being so withheld by the company in an amount equal to the product of x such incremental fraction of a share being so withheld multiplied by y the fair market value per warrant share as of the exercise date   c           delivery of stock certificates  upon receipt by the company of the exercise agreement and payment of the aggregate exercise price in accordance with section a hereof the company shall as promptly as practicable and in any event within five  business days thereafter execute or cause to be executed and deliver or cause to be delivered to the holder a certificate or certificates representing the warrant shares issuable upon such exercise together with cash in lieu of any fraction of a share as provided in section d hereof the stock certificate or certificates so delivered shall be to the extent possible in such denomination or denominations as the exercising holder shall reasonably request in the exercise agreement and shall be registered in the name of the holder or subject to compliance with section  below such other person’s name as shall be designated in the exercise agreement this warrant shall be deemed to have been exercised and such certificate or certificates of warrant shares shall be deemed to have been issued and the holder or any other person so designated to be named therein shall be deemed to have become a holder of record of such warrant shares for all purposes as of the exercise date   d           fractional shares  the company shall not be required to issue a fractional warrant share upon exercise of any warrant as to any fraction of a warrant share that the holder would otherwise be entitled to purchase upon such exercise the company shall pay to such holder an amount in cash by delivery of a certified or official bank check or by wire transfer of immediately available funds equal to the product of i such fraction multiplied by ii the volume weighted average price of the common stock on the exercise date as reported by bloomberg lp            e           surrender of this warrant  notwithstanding anything herein to the contrary the holder shall not be required to physically surrender this warrant to the company until the holder has purchased all of the warrant shares available hereunder and the warrant has been exercised in full in which case the holder shall surrender this warrant to the company for cancellation within three  business days of the date the final exercise agreement is delivered to the company partial exercises of this warrant resulting in purchases of a portion of the total number of warrant shares available hereunder shall have the effect of lowering the outstanding number of warrant shares purchasable hereunder in an amount equal to the applicable number of warrant shares purchased the holder and the company shall maintain records showing the number of warrant shares purchased and the date of such purchases the holder and any assignee by acceptance of this warrant acknowledge and agree that by reason of the provisions of this paragraph following the purchase of a portion of the warrant shares hereunder the number of warrant shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof   f           valid issuance of warrant and warrant shares payment of taxes  with respect to the exercise of this warrant the company hereby represents covenants and agrees   i          this warrant is and any warrant issued in substitution for or replacement of this warrant shall be upon issuance duly authorized and validly issued   ii         all warrant shares issuable upon the exercise of this warrant pursuant to the terms hereof shall be upon issuance and the company shall take all such actions as may be necessary or appropriate in order that such warrant shares are validly issued fully paid and nonassessable issued without violation of any preemptive or similar rights of any stockholder of the company and free and clear of all taxes liens and charges   iii        the company shall take all such actions as may be necessary to ensure that all such warrant shares are issued without violation by the company of any applicable law or governmental regulation or any requirements of any domestic securities exchange upon which shares of common stock or other securities constituting warrant shares may be listed at the time of such exercise except for official notice of issuance which shall be immediately delivered by the company upon each such issuance   iv        the company shall cause the warrant shares immediately upon such exercise to be listed on any domestic securities exchange upon which shares of common stock or other securities constituting warrant shares are listed at the time of such exercise   v         the company shall pay all expenses in connection with and all taxes and other governmental charges that may be imposed with respect to the issuance or delivery of warrant shares upon exercise of this warrant            g           conditional exercise  notwithstanding any other provision hereof if an exercise of any portion of this warrant is to be made in connection with a public offering or a sale of the company pursuant to a merger sale of stock or otherwise such exercise may at the election of the holder be conditioned upon the consummation of such transaction in which case such exercise shall not be deemed to be effective until immediately prior to the consummation of such transaction   h           reservation of shares  during the exercise period the company shall at all times reserve and keep available out of its authorized but unissued common stock or other securities constituting warrant shares solely for the purpose of issuance upon the exercise of this warrant the maximum number of warrant shares issuable upon the exercise of this warrant and the par value per warrant share shall at all times be less than or equal to the applicable exercise price the company shall not increase the par value of any warrant shares receivable upon the exercise of this warrant above the exercise price then in effect and shall take all such actions as may be necessary or appropriate in order that the company may validly and legally issue fully paid and nonassessable shares of common stock upon the exercise of this warrant   section             adjustment to exercise price and number of warrant shares  in order to prevent dilution of the purchase rights granted under this warrant the exercise price and the number of warrant shares issuable upon exercise of this warrant shall be subject to adjustment from time to time as provided in this section     a           adjustment to exercise price upon issuance of common stock  except as provided in section b and except in the case of an event described in either section d or section e  if the company shall at any time or from time to time after the issue date issue or sell or in accordance with section d is deemed to have issued or sold any shares of common stock without consideration or for consideration per share less than the exercise price in effect immediately prior to such issuance or sale or deemed issuance or sale then immediately upon such issuance or sale or deemed issuance or sale the exercise price in effect immediately prior to such issuance or sale or deemed issuance or sale shall be reduced and in no event increased to an exercise price equal to the quotient obtained by dividing   i          the sum of a the product obtained by multiplying the common stock deemed outstanding immediately prior to such issuance or sale or deemed issuance or sale by the exercise price then in effect plus b the aggregate consideration if any received or to be received by the company upon such issuance or sale or deemed issuance or sale by   ii         the sum of a the common stock deemed outstanding immediately prior to such issuance or sale or deemed issuance or sale plus b the aggregate number of shares of common stock issued or sold or to be issued or sold or deemed issued or sold by the company in such issuance or sale or deemed issuance or sale            b           exceptions to adjustment upon issuance of common stock  anything herein to the contrary notwithstanding there shall be no adjustment to the exercise price or the number of warrant shares issuable upon exercise of this warrant with respect to any excluded issuance   c           effect of certain events on adjustment to exercise price  for purposes of determining the adjusted exercise price under section a hereof the following shall be applicable   i           issuance of options  if the company shall at any time or from time to time after the issue date in any manner grant or sell whether directly or by assumption in a merger or otherwise any options whether or not such options or the right to convert or exchange any convertible securities issuable upon the exercise of such options are immediately exercisable and the price per share determined as provided in this paragraph and in section cv  for which common stock is issuable upon the exercise of such options or upon the conversion or exchange of convertible securities issuable upon the exercise of such options is less than the exercise price in effect immediately prior to the time of the granting or sale of such options then the total maximum number of shares of common stock issuable upon the exercise of such options or upon conversion or exchange of the total maximum amount of convertible securities issuable upon the exercise of such options shall be deemed to have been issued as of the date of granting or sale of such options and thereafter shall be deemed to be outstanding for purposes of adjusting the exercise price under section a  at a price per share equal to the quotient obtained by dividing a the sum which sum shall constitute the applicable consideration received for purposes of section a of x the total amount if any received or receivable by the company as consideration for the granting or sale of all such options plus y the minimum aggregate amount of additional consideration if any payable to the company upon the exercise of all such options plus z in the case of such options which relate to convertible securities the minimum aggregate amount of additional consideration if any payable to the company upon the issuance or sale of all such convertible securities and the conversion or exchange of all such convertible securities by b the total maximum number of shares of common stock issuable upon the exercise of all such options or upon the conversion or exchange of all convertible securities issuable upon the exercise of all such options except as otherwise provided in section ciii  no further adjustment of the exercise price shall be made upon the actual issuance of common stock or of convertible securities upon exercise of such options or upon the actual issuance of common stock upon conversion or exchange of convertible securities issuable upon exercise of such options            ii          issuance of convertible securities  if the company shall at any time or from time to time after the issue date in any manner grant or sell whether directly or by assumption in a merger or otherwise any convertible securities whether or not the right to convert or exchange any such convertible securities is immediately exercisable and the price per share determined as provided in this paragraph and in section cv  for which common stock is issuable upon the conversion or exchange of such convertible securities is less than the exercise price in effect immediately prior to the time of the granting or sale of such convertible securities then the total maximum number of shares of common stock issuable upon conversion or exchange of the total maximum amount of such convertible securities shall be deemed to have been issued as of the date of granting or sale of such convertible securities and thereafter shall be deemed to be outstanding for purposes of adjusting the exercise price pursuant to section a  at a price per share equal to the quotient obtained by dividing a the sum which sum shall constitute the applicable consideration received for purposes of section a of x the total amount if any received or receivable by the company as consideration for the granting or sale of such convertible securities plus y the minimum aggregate amount of additional consideration if any payable to the company upon the conversion or exchange of all such convertible securities by b the total maximum number of shares of common stock issuable upon the conversion or exchange of all such convertible securities except as otherwise provided in section ciii  a no further adjustment of the exercise price shall be made upon the actual issuance of common stock upon conversion or exchange of such convertible securities and b no further adjustment of the exercise price shall be made by reason of the issue or sale of convertible securities upon exercise of any options to purchase any such convertible securities for which adjustments of the exercise price have been made pursuant to the other provisions of this section c    iii         change in terms of options or convertible securities  upon any change in any of a the total amount received or receivable by the company as consideration for the granting or sale of any options or convertible securities referred to in section ci or section cii hereof b the minimum aggregate amount of additional consideration if any payable to the company upon the exercise of any options or upon the issuance conversion or exchange of any convertible securities referred to in section ci or section cii hereof c the rate at which convertible securities referred to in section ci or section cii hereof are convertible into or exchangeable for common stock or d the maximum number of shares of common stock issuable in connection with any options referred to in section ci hereof or any convertible securities referred to in section cii hereof in each case other than in connection with an excluded issuance then whether or not the original issuance or sale of such options or convertible securities resulted in an adjustment to the exercise price pursuant to this section   the exercise price in effect at the time of such change shall be adjusted or readjusted as applicable to the exercise price which would have been in effect at such time pursuant to the provisions of this section  had such options or convertible securities still outstanding provided for such changed consideration conversion rate or maximum number of shares as the case may be at the time initially granted issued or sold but only if as a result of such adjustment or readjustment the exercise price then in effect is reduced   iv         treatment of expired or terminated options or convertible securities  upon the expiration or termination of any unexercised option or portion thereof or any unconverted or unexchanged convertible security or portion thereof for which any adjustment either upon its original issuance or upon a revision of its terms was made pursuant to this section  including without limitation upon the redemption or purchase for consideration of all or any portion of such option or convertible security by the company the exercise price then in effect hereunder shall forthwith be changed pursuant to the provisions of this section  to the exercise price which would have been in effect at the time of such expiration or termination had such unexercised option or portion thereof or unconverted or unexchanged convertible security or portion thereof to the extent outstanding immediately prior to such expiration or termination never been issued            v          calculation of consideration received  if the company shall at any time or from time to time after the issue date issue or sell or is deemed to have issued or sold in accordance with section d  any shares of common stock options or convertible securities a for cash the consideration received therefor shall be deemed to be the net amount received by the company therefor b marketable securities the amount of consideration shall be the fair market value of such securities c for consideration other than cash or marketable securities the amount of the consideration other than cash or marketable securities received by the company shall be the fair value of such consideration d for no specifically allocated consideration in connection with an issuance or sale of other securities of the company together comprising one integrated transaction the amount of the consideration therefor shall be deemed to be the fair value of such portion of the aggregate consideration received by the company in such transaction as is attributable to such shares of common stock options or convertible securities as the case may be issued in such transaction or e to the owners of the nonsurviving entity in connection with any merger in which the company is the surviving corporation the amount of consideration therefor shall be deemed to be the fair value of such portion of the net assets and business of the nonsurviving entity as is attributable to such shares of common stock options or convertible securities as the case may be issued to such owners for purposes of this clause v  the net amount of any cash consideration and the fair value of any consideration other than cash or marketable securities shall be determined in good faith jointly by the board and the holder   vi         record date  for purposes of any adjustment to the exercise price or the number of warrant shares in accordance with this section   in case the company shall take a record of the holders of its common stock for the purpose of entitling them a to receive a dividend or other distribution payable in common stock options or convertible securities or b to subscribe for or purchase common stock options or convertible securities then such record date shall be deemed to be the date of the issue or sale of the shares of common stock deemed to have been issued or sold upon the declaration of such dividend or the making of such other distribution or the date of the granting of such right of subscription or purchase as the case may be   vii        treasury shares  the number of shares of common stock outstanding at any given time shall not include shares owned or held by or for the account of the company or any of its whollyowned subsidiaries and the disposition of any such shares other than the cancellation or retirement thereof or the transfer of such shares among the company and its whollyowned subsidiaries shall be considered an issue or sale of common stock for the purpose of this section              viii       other dividends and distributions  subject to the provisions of this section c  if the company shall at any time or from time to time after the issue date make or declare or fix a record date for the determination of holders of common stock entitled to receive a dividend or any other distribution payable in cash securities of the company other than a dividend or distribution of shares of common stock options or convertible securities in respect of outstanding shares of common stock or other property then and in each such event provision shall be made so that the holder shall receive upon exercise of the warrant in addition to the number of warrant shares receivable thereupon the kind and amount of cash securities of the company or other property which the holder would have been entitled to receive had the warrant been exercised in full into warrant shares on the date of such event and had the holder thereafter during the period from the date of such event to and including the exercise date retained such cash securities or other property receivable by them as aforesaid during such period giving application to all adjustments called for during such period under this section  with respect to the rights of the holder provided  that no such provision shall be made if i the holder receives simultaneously with the distribution to the holders of common stock a dividend or other distribution of such securities cash or other property in an amount equal to the amount of such cash securities or other property as the holder would have received if the warrant had been exercised in full into warrant shares on the date of such event or ii an adjustment is made to this warrant pursuant to section d    d           adjustment to exercise price and warrant shares upon dividend subdivision or combination of common stock  if the company shall at any time or from time to time after the issue date i pay a dividend or make any other distribution upon the common stock or any other capital stock of the company payable in shares of common stock or in options or convertible securities or ii subdivide by any stock split recapitalization or otherwise its outstanding shares of common stock into a greater number of shares the exercise price in effect immediately prior to any such dividend distribution or subdivision shall be proportionately reduced and the number of warrant shares issuable upon exercise of this warrant shall be proportionately increased if the company at any time combines by combination reverse stock split or otherwise its outstanding shares of common stock into a smaller number of shares the exercise price in effect immediately prior to such combination shall be proportionately increased and the number of warrant shares issuable upon exercise of this warrant shall be proportionately decreased any adjustment under this section d shall become effective at the close of business on the date the dividend subdivision or combination becomes effective            e           adjustment to exercise price and warrant shares upon reorganization reclassification consolidation or merger  in the event of any i capital reorganization of the company ii reclassification of the stock of the company other than a change in par value or from par value to no par value or from no par value to par value or as a result of a stock dividend or subdivision splitup or combination of shares iii consolidation merger or similar transaction of the company with or into one or more other persons iv sale of all or substantially all of the company’s assets to one or more other persons or v other similar transaction other than any such transaction covered by section d  in each case which entitles the holders of common stock to receive either directly or upon subsequent liquidation stock securities or assets with respect to or in exchange for common stock each warrant shall immediately after such reorganization reclassification consolidation merger sale or similar transaction remain outstanding and shall thereafter in lieu of or in addition to as the case may be the number of warrant shares then exercisable under this warrant be exercisable for the kind and number of shares of stock or other securities or assets of the company or of each successor person resulting from such transaction to which the holder would have been entitled upon such reorganization reclassification consolidation merger sale or similar transaction if the holder had exercised this warrant in full immediately prior to the time of such reorganization reclassification consolidation merger sale or similar transaction and acquired the applicable number of warrant shares then issuable hereunder as a result of such exercise without taking into account any limitations or restrictions on the exercisability of this warrant and in such case appropriate adjustment in form and substance satisfactory to the holder shall be made with respect to the holder’s rights under this warrant to insure that the provisions of this section  hereof shall thereafter be applicable as nearly as possible to this warrant in relation to any shares of stock securities or assets thereafter acquirable upon exercise of this warrant including in the case of any consolidation merger sale or similar transaction in which the successor or purchasing person is other than the company an immediate adjustment in the exercise price to the value per share for the common stock reflected by the terms of such consolidation merger sale or similar transaction if the value so reflected is less than the exercise price in effect immediately prior to such consolidation merger sale or similar transaction the provisions of this section e shall similarly apply to successive reorganizations reclassifications consolidations mergers sales or similar transactions the company shall not effect any such reorganization reclassification consolidation merger sale or similar transaction unless prior to the consummation thereof the successor person if other than the company resulting from such reorganization reclassification consolidation merger sale or similar transaction shall assume by written instrument substantially similar in form and substance to this warrant and satisfactory to the holder the obligation to deliver to the holder such shares of stock securities or assets which in accordance with the foregoing provisions such holder shall be entitled to receive upon exercise of this warrant notwithstanding anything to the contrary contained herein with respect to any corporate event or other transaction contemplated by the provisions of this section e  the holder shall have the right to elect prior to the consummation of such event or transaction to give effect to the exercise rights contained in section  instead of giving effect to the provisions contained in this section e with respect to this warrant   f           certain events  if any event of the type contemplated by the provisions of this section  but not expressly provided for by such provisions including without limitation the granting of stock appreciation rights phantom stock rights or other rights with equity features occurs then the board shall make an appropriate adjustment in the exercise price and the number of warrant shares issuable upon exercise of this warrant so as to protect the rights of the holder in a manner consistent with the provisions of this section   provided  that no such adjustment pursuant to this section f shall increase the exercise price or decrease the number of warrant shares issuable as otherwise determined pursuant to this section              g           certificate as to adjustment    i          as promptly as reasonably practicable following any adjustment of the exercise price but in any event not later than five  business days thereafter the company shall furnish to the holder a certificate of an executive officer setting forth in reasonable detail such adjustment and the facts upon which it is based and certifying the calculation thereof   ii         as promptly as reasonably practicable following the receipt by the company of a written request by the holder but in any event not later than five  business days thereafter the company shall furnish to the holder a certificate of an executive officer certifying the exercise price then in effect and the number of warrant shares or the amount if any of other shares of stock securities or assets then issuable upon exercise of the warrant   h           notices  in the event   i          that the company shall take a record of the holders of its common stock or other capital stock or securities at the time issuable upon exercise of the warrant for the purpose of entitling or enabling them to receive any dividend or other distribution to vote at a meeting or by written consent to receive any right to subscribe for or purchase any shares of capital stock of any class or any other securities or to receive any other security or   ii         of any capital reorganization of the company any reclassification of the common stock of the company any consolidation or merger of the company with or into another person or sale of all or substantially all of the company’s assets to another person or   iii        of the voluntary or involuntary dissolution liquidation or windingup of the company   then and in each such case the company shall send or cause to be sent to the holder at least five  business days prior to the applicable record date or the applicable expected effective date as the case may be for the event a written notice specifying as the case may be a the record date for such dividend distribution meeting or consent or other right or action and a description of such dividend distribution or other right or action to be taken at such meeting or by written consent or b the effective date on which such reorganization reclassification consolidation merger sale dissolution liquidation or windingup is proposed to take place and the date if any is to be fixed as of which the books of the company shall close or a record shall be taken with respect to which the holders of record of common stock or such other capital stock or securities at the time issuable upon exercise of the warrant shall be entitled to exchange their shares of common stock or such other capital stock or securities for securities or other property deliverable upon such reorganization reclassification consolidation merger sale dissolution liquidation or windingup and the amount per share and character of such exchange applicable to the warrant and the warrant shares            section             purchase rights  in addition to any adjustments pursuant to section  above if at any time the company grants issues or sells any shares of common stock options convertible securities or rights to purchase stock warrants securities or other property pro rata to the record holders of common stock the “ purchase rights ” then the holder shall be entitled to but shall not be obligated to acquire upon the same terms applicable to such purchase rights the aggregate purchase rights which the holder would have acquired if the holder had held the number of warrant shares acquirable upon complete exercise of this warrant immediately before the date on which a record is taken for the grant issuance or sale of such purchase rights or if no such record is taken the date as of which the record holders of common stock are to be determined for the grant issue or sale of such purchase rights anything herein to the contrary notwithstanding the holder shall not be entitled to the purchase rights granted herein with respect to any excluded issuance   section             registration rights  the parties hereto agree that all warrant shares issued upon exercise of this warrant are and shall be subject to and shall have the benefit of the registration rights the “ registration rights ” set forth in addendum i hereto the “ registration rights addendum ” the terms and provisions of the registration rights addendum shall be binding upon the company the holder and their respective successors transferees and assigns as if set forth in full within this warrant notwithstanding the foregoing no holder shall be entitled to request any demand registration or piggyback registration unless such holder either individually or acting in concert with other holders participating in such request hold at least  of the number of warrant shares issuable upon exercise of this warrant on the issue date   section             transfer of warrant  subject to section  above and the transfer conditions referred to in the legend endorsed hereon this warrant and all rights hereunder are transferable in whole or in part by the holder without charge to the holder upon surrender of this warrant to the company at its then principal executive offices with a properly completed and duly executed assignment in the form attached hereto as exhibit b  together with funds sufficient to pay any transfer taxes described in section fv in connection with the making of such transfer upon such compliance surrender and delivery and if required such payment the company shall execute and deliver a new warrant or warrants in the name of the assignee or assignees and in the denominations specified in such instrument of assignment and shall issue to the assignor a new warrant evidencing the portion of this warrant if any not so assigned and this warrant shall promptly be cancelled              section              holder not deemed a stockholder limitations on liability  except as otherwise specifically provided herein including section cviii  prior to the issuance to the holder of the warrant shares to which the holder is then entitled to receive upon the due exercise of this warrant the holder shall not be entitled to vote or receive dividends or be deemed the holder of shares of capital stock of the company for any purpose nor shall anything contained in this warrant be construed to confer upon the holder as such any of the rights of a stockholder of the company or any right to vote give or withhold consent to any corporate action whether any reorganization issue of stock reclassification of stock consolidation merger conveyance or otherwise receive notice of meetings receive dividends or subscription rights or otherwise in addition nothing contained in this warrant shall be construed as imposing any liabilities on the holder to purchase any securities upon exercise of this warrant or otherwise or as a stockholder of the company whether such liabilities are asserted by the company or by creditors of the company notwithstanding this section   the company shall provide the holder with copies of the same notices and other information given to the stockholders of the company generally contemporaneously with the giving thereof to the stockholders   section               replacement on loss division and combination    i           replacement of warrant on loss  upon receipt of evidence reasonably satisfactory to the company of the loss theft destruction or mutilation of this warrant and upon delivery of an indemnity reasonably satisfactory to it it being understood that a written indemnification agreement or affidavit of loss of the holder shall be a sufficient indemnity and in case of mutilation upon surrender of such warrant for cancellation to the company the company at its own expense shall execute and deliver to the holder in lieu hereof a new warrant of like tenor and exercisable for an equivalent number of warrant shares as the warrant so lost stolen mutilated or destroyed provided  that in the case of mutilation no indemnity shall be required if this warrant in identifiable form is surrendered to the company for cancellation   j           division and combination of warrant  subject to compliance with the applicable provisions of this warrant as to any transfer or other assignment which may be involved in such division or combination this warrant may be divided or following any such division of this warrant subsequently combined with other warrants upon the surrender of this warrant or warrants to the company at its then principal executive offices together with a written notice specifying the names and denominations in which new warrants are to be issued signed by the respective holders or their agents or attorneys subject to compliance with the applicable provisions of this warrant as to any transfer or assignment which may be involved in such division or combination the company shall at its own expense execute and deliver a new warrant or warrants in exchange for the warrant or warrants so surrendered in accordance with such notice such new warrant or warrants shall be of like tenor to the surrendered warrant or warrants and shall be exercisable in the aggregate for an equivalent number of warrant shares as the warrant or warrants so surrendered in accordance with such notice            section            no impairment  the company shall not by amendment of its certificate of incorporation or bylaws through any shareholders voting or similar agreement or through any reorganization transfer of assets consolidation merger dissolution issue or sale of securities or any other voluntary action avoid or seek to avoid the observance or performance of any of the terms to be observed or performed by it hereunder but shall at all times in good faith assist in the carrying out of all the provisions of this warrant and in the taking of all such action as may reasonably be requested by the holder in order to protect the exercise rights of the holder against dilution or other impairment consistent with the tenor and purpose of this warrant   section            compliance with the securities act    k           agreement to comply with the securities act legend  the holder by acceptance of this warrant agrees to comply in all respects with the provisions of this section  and the restrictive legend requirements set forth on the face of this warrant and further agrees that such holder shall not offer sell or otherwise dispose of this warrant or any warrant shares to be issued upon exercise hereof except under circumstances that will not result in a violation of the securities act of  as amended the “ securities act ” this warrant and all warrant shares issued upon exercise of this warrant unless registered under the securities act shall be stamped or imprinted with a legend in substantially the following form   “this warrant and the securities issuable upon exercise of this warrant have not been registered under the securities act of  as amended the “ act ” or qualified under any state or foreign securities laws and may not be offered for sale sold pledged hypothecated or otherwise transferred or assigned unless i a registration statement covering such shares is effective under the act and is qualified under applicable state and foreign law or ii the transaction is exempt from the registration and prospectus delivery requirements under the act and the qualification requirements under applicable state and foreign law and if the corporation requests an opinion satisfactory to the corporation to such effect has been rendered by counsel”   l           representations of the holder  in connection with the issuance of this warrant the holder specifically represents as of the date hereof to the company by acceptance of this warrant as follows   i          the holder is an “accredited investor” as defined in rule  of regulation d promulgated under the securities act the holder is acquiring this warrant and the warrant shares to be issued upon exercise hereof for investment for its own account and not with a present view towards or for resale in connection with the public sale or distribution of this warrant or the warrant shares except pursuant to sales registered or exempted under the securities act            ii         the holder understands and acknowledges that this warrant and the warrant shares to be issued upon exercise hereof are “restricted securities” under the federal securities laws inasmuch as they are being acquired from the company in a transaction not involving a public offering and that under such laws and applicable regulations such securities may be resold without registration under the securities act only in certain limited circumstances in addition the holder represents that it is familiar with rule  under the securities act as presently in effect and understands the resale limitations imposed thereby and by the securities act   iii        the holder acknowledges that it can bear the economic and financial risk of its investment for an indefinite period and has such knowledge and experience in financial or business matters that it is capable of evaluating the merits and risks of the investment in the warrant and the warrant shares the holder has had an opportunity to ask questions and receive answers from the company regarding the terms and conditions of the offering of the warrant and the business properties prospects and financial condition of the company   section            warrant register  the company shall keep and properly maintain at its principal executive offices a register the “ warrant register ” for the registration of the warrant and any transfers thereof the company may deem and treat the person in whose name the warrant is registered on such register as the holder thereof for all purposes and the company shall not be affected by any notice to the contrary except any assignment division combination or other transfer of the warrant effected in accordance with the provisions of this warrant   section            notices  all notices requests consents claims demands waivers and other communications hereunder or under the registration rights addendum shall be in writing and shall be deemed to have been given i when delivered by hand with written confirmation of receipt ii when received by the addressee if sent by a nationally recognized overnight courier receipt requested iii on the date sent by facsimile or email of a pdf document with confirmation of transmission if sent during normal business hours of the recipient and on the next business day if sent after normal business hours of the recipient or iv on the third day after the date mailed by certified or registered mail return receipt requested postage prepaid such communications must be sent to the respective parties at the addresses indicated below or at such other address for a party as shall be specified in a notice given in accordance with this section     if to the company alliqua biomedical inc  stony hill road yardley pa    email bposneralliquacom      attention brian posner     chief financial officer            with a copy to haynes and boone llp  rockefeller plaza  th floor new york ny    email rickwernerhaynesboonecom     attention rick a warner esq   if to the holder perceptive credit holdings lp co perceptive advisors llc  astor place th floor new york ny    email sandeepperceptivelifecom     attention sandeep dixit   with a copy to morrison  foerster llp  west  th street new york ny    email mwojciechowskimofocom     attention mark s wojciechowski esq   section           cumulative remedies  except to the extent expressly provided in section  to the contrary the rights and remedies provided in this warrant and the registration rights addendum are cumulative and are not exclusive of and are in addition to and not in substitution for any other rights or remedies available at law in equity or otherwise   section           equitable relief  each of the company and the holder acknowledges that a breach or threatened breach by such party of any of its obligations under this warrant or the registration rights addendum would give rise to irreparable harm to the other party hereto for which monetary damages would not be an adequate remedy and hereby agrees that in the event of a breach or a threatened breach by such party of any such obligations the other party hereto shall in addition to any and all other rights and remedies that may be available to it in respect of such breach be entitled to equitable relief including a restraining order an injunction specific performance and any other relief that may be available from a court of competent jurisdiction            section           entire agreement  this warrant together with the credit agreement and the registration rights addendum constitutes the sole and entire agreement of the parties to this warrant with respect to the subject matter contained herein and supersedes all prior and contemporaneous understandings and agreements both written and oral with respect to such subject matter in the event of any inconsistency between the statements in the body of this warrant the credit agreement and the registration rights addendum the statements in the body of this warrant shall control   section           successor and assigns  this warrant the registration rights addendum and the rights evidenced hereby and thereby shall be binding upon and shall inure to the benefit of the parties hereto and the successors of the company and the successors transferees and permitted assigns of the holder such successors andor permitted assigns of the holder shall be deemed to be a holder for all purposes hereunder   section           no thirdparty beneficiaries  this warrant and the registration rights addendum are for the sole benefit of the company and the holder and their respective successors and in the case of the holder permitted transferees and assigns and nothing herein express or implied is intended to or shall confer upon any other person any legal or equitable right benefit or remedy of any nature whatsoever under or by reason of this warrant and the registration rights addendum   section           headings  the headings in this warrant and the registration rights addendum are for reference only and shall not affect the interpretation of this warrant or the registration rights addendum   section           amendment and modification waiver  except as otherwise provided herein this warrant and the registration rights addendum may only be amended modified or supplemented by an agreement in writing signed by each party hereto no waiver by the company or the holder of any of the provisions hereof or thereof shall be effective unless explicitly set forth in writing and signed by the party so waiving no waiver by any party shall operate or be construed as a waiver in respect of any failure breach or default not expressly identified by such written waiver whether of a similar or different character and whether occurring before or after that waiver no failure to exercise or delay in exercising any rights remedy power or privilege arising from this warrant or the registration rights addendum shall operate or be construed as a waiver thereof nor shall any single or partial exercise of any right remedy power or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right remedy power or privilege   section           severability  if any term or provision of this warrant or the registration rights addendum is invalid illegal or unenforceable in any jurisdiction such invalidity illegality or unenforceability shall not affect any other term or provision of this warrant or the registration rights addendum or invalidate or render unenforceable such term or provision in any other jurisdiction            section           governing law  this warrant and the registration rights addendum shall be governed by and construed in accordance with the internal laws of the state of new york without giving effect to any choice or conflict of law provision or rule whether of the state of new york or any other jurisdiction that would cause the application of laws of any jurisdiction other than those of the state of new york   section           submission to jurisdiction  any legal suit action or proceeding arising out of or based upon this warrant the registration rights addendum or the transactions contemplated hereby or thereby shall be instituted in the state or federal courts sitting in the borough of manhattan in the city of new york new york and each party irrevocably submits to the exclusive jurisdiction of such courts in any such suit action or proceeding service of process summons notice or other document by certified or registered mail to such party’s address set forth herein shall be effective service of process for any suit action or other proceeding brought in any such court the parties irrevocably and unconditionally waive any objection to the laying of venue of any suit action or any proceeding in such courts and irrevocably waive and agree not to plead or claim in any such court that any such suit action or proceeding brought in any such court has been brought in an inconvenient forum   section           waiver of jury trial  each party acknowledges and agrees that any controversy which may arise under this warrant or the registration rights addendum is likely to involve complicated and difficult issues and therefore each such party irrevocably and unconditionally waives any right it may have to a trial by jury in respect of any legal action arising out of or relating to this warrant or the registration rights addendum or the transactions contemplated hereby or thereby   section           counterparts  this warrant may be executed in counterparts each of which shall be deemed an original but all of which together shall be deemed to be one and the same agreement a signed copy of this warrant delivered by facsimile email or other means of electronic transmission shall be deemed to have the same legal effect as delivery of an original signed copy of this warrant   section           no strict construction  this warrant and the registration rights addendum shall be construed without regard to any presumption or rule requiring construction or interpretation against the party drafting an instrument or causing any instrument to be drafted   signature page follows            in witness whereof the company has duly executed this warrant on the issue date     alliqua biomedical inc        by s brian m posner   name brian m posner   title cfo    accepted and agreed   perceptive credit holdings lp       by perceptive credit opportunities gp llc       by  s sandeep dixit   name sandeep dixit   title chief credit officer     by  s sam chaula   name sam chaula   title portfolio manager           exhibit a to warrant   form of exercise agreement   to be signed only upon exercise of the warrant   to    the undersigned as holder of a right to purchase shares of common stock of alliqua biomedical inc a delaware corporation the “ company ” pursuant to that certain warrant of the company having an original issue date of of may   and bearing warrant certificate no  as subsequently amended or otherwise modified since such original issue date the “ warrant ” hereby irrevocably elects to exercise the purchase right represented by such warrant for and to purchase thereunder   shares of common stock of the company and herewith makes payment of  dollars  therefor by the following method     check all that apply    check if applicable     the undersigned hereby elects to make payment of the aggregate exercise price of  dollars  for  shares of common stock using the method described in section bi         check if applicable     the undersigned hereby elects to make payment of the aggregate exercise price of  dollars  for  shares of common stock using the method described in section bii     unless otherwise defined herein capitalized terms have the meanings provided in the warrant   dated      name of warrant holder       by    name   title      note  no more than onehalf  of the aggregate exercise price may be paid by using the method described in section bii          exhibit b to warrant   form of assignment agreement   the undersigned  is the holder in such capacity the “ holder ” of a warrant having an original issue date of may   as subsequently amended or otherwise modified since such original issue date the “ warrant ” by alliqua biomedical inc the “ company ” bearing warrant certificate no  entitling the holder to purchase up to  shares of the company’s common stock unless otherwise defined capitalized terms used herein have the meanings ascribed thereto in the warrant   for value received the holder hereby sells assigns and transfers to  the “ assignee ” the right to acquire all warrant shares entitled to be purchased upon exercise of the warrant  of the warrant shares entitled to be purchased upon exercise of the warrant in furtherance of the foregoing assignment the holder hereby irrevocably instructs the company to i memorialize such assignment on the warrant register as required pursuant to section  of the warrant and ii pursuant to section  of the warrant execute and deliver to the assignee and the holder a new warrant new warrants reflecting the foregoing assignment each a “ substitute warrant ”   the assignee acknowledges and agrees that its substitute warrant and the shares of common stock to be issued upon exercise or conversion thereof are being acquired for investment and that the assignee will not offer sell or otherwise dispose of its substitute warrant or any shares of stock to be issued upon exercise or conversion thereof except under circumstances which will not result in a violation of the securities act or any applicable state securities laws the assignee represents and warrants for the benefit of the company that the assignee is an “accredited investor” within the meaning of rule  of regulation d promulgated under the securities act of  as amended   accordingly the following restrictive legend is made applicable to the assignee’s substitute warrant and the securities covered thereby   the substitute warrant being issued in connection with the assignment contemplated hereby along with the securities to be issued upon the exercise thereof have not been registered under the securities act and may not be offered sold or otherwise transferred assigned pledged or hypothecated in the absence of such registration or any exemption therefrom under such securities act any applicable state securities laws and the rules and regulations thereunder   signature page follows            name of holder       by    name   title   address       name of assignee       by    name   title   address            addendum i to warrant   registration rights addendum   reference is made to the warrant having an original issue date of may   as subsequently amended or otherwise modified since such original issue date the “ warrant ” by and between alliqua biomedical inc the “ company ” and perceptive credit holdings lp   unless otherwise defined capitalized terms used herein have the meanings ascribed thereto pursuant to section  of the warrant   the terms and provisions of this addendum i this “ addendum ” form a part of the warrant as if set forth in full therein and the parties thereto are bound by and entitled to the benefits and subject to the obligations of the terms and provisions hereof as if set forth in full in the warrant               defined terms  as used in this addendum the following terms shall have the following meanings   “ addendum ” has the meaning set forth in the preamble   “ demand registration ” has the meaning set forth in section a    “ holder ” means the initial holder as defined in the warrant and all permitted transferees successors and assigns of the initial holder and their respective permitted transferees successors and assigns in any case subject to section  of the warrant it being understood that for purposes of this addendum a person shall be deemed to be a holder whenever such person holds a warrant has the right to acquire or obtain from the company any registrable securities upon exercise of such warrant has acquired registrable securities upon exercise of a warrant or has acquired registrable securities after the exercise of a warrant as a result of any subsequent stock split stock combination dividend distribution recapitalization or similar event   “ inspectors ” has the meaning set forth in section h    “ piggyback registration ” has the meaning set forth in section a    “ prospectus ” means the prospectus or prospectuses included in any registration statement as amended or supplemented by any prospectus supplement with respect to the terms of the offering of any portion of the securities covered by such registration statement and by all other amendments and supplements to the prospectus including posteffective amendments and all material incorporated by reference in such prospectus or prospectuses   “ records ” has the meaning set forth in section h          “ registrable securities ” means i any shares of common stock issuable upon exercise or exchange of a warrant and ii any shares of common stock issued or issuable with respect to any shares described in clause i above by way of a stock dividend or stock split or in connection with a combination of shares recapitalization merger consolidation or other reorganization as to any particular registrable securities such securities shall cease to be registrable securities when i a registration statement covering such securities has been declared effective by the sec and such securities have been disposed of pursuant to such effective registration statement ii such securities are sold under circumstances in which all of the applicable conditions of rule  or any similar provisions then in force under the securities act are met iii such securities may be resold without subsequent registration under the securities act or iv such securities shall have ceased to be outstanding   “ registration statement ” means any registration statement of the company which covers any of the registrable securities pursuant to the provisions of this addendum including the prospectus amendments and supplements to such registration statement including posteffective amendments all exhibits and all materials incorporated by reference in such registration statement   “ rule  ” means rule  promulgated under the securities act or any successor rule thereto   “ securities act ” means the securities act of  as amended or any successor federal statute and the rules and regulations thereunder which shall be in effect from time to time   “ selling expenses ” means all underwriting discounts selling commissions and stock transfer taxes applicable to the sale of registrable securities and fees and disbursements of counsel for any holder except for the reasonable fees and disbursements of counsel for the holders of registrable securities required to be paid by the company pursuant to section                 demand registration  the company agrees as follows   a          the company shall at all times use its reasonable best efforts to qualify and remain qualified to register securities under the securities act pursuant to a registration statement on form s or any successor form thereto the holders shall have the right to request  registrations of their registrable securities on form s or any similar shortform registration each a “ demand registration ” each request for a demand registration shall specify the approximate number of registrable securities requested to be registered upon receipt of any such request the company shall promptly but in no event later than ten  days following receipt thereof deliver notice of such request to all other holders of registrable securities who shall then have ten  days from the date such notice is given to notify the company in writing of their desire to be included in such registration the company shall cause a registration statement on form s or any successor form to be filed within thirty  days after the date on which the initial request is given and shall use its reasonable best efforts to cause such registration statement to be declared effective by the sec as soon as practicable thereafter            b          the company shall not be obligated to effect any demand registration within one hundred twenty  days after the effective date of a previous demand registration pursuant to which holders of registrable securities were permitted to register and actually sold at least  of the shares of registrable securities requested to be included therein the company may postpone for up to ninety  days the filing or effectiveness of a registration statement for a demand registration if the company’s board determines in its reasonable good faith judgment that such demand registration would i materially interfere with a significant acquisition corporate organization public or private offering of the company’s securities or other transaction similar to any of the foregoing involving the company ii require premature disclosure of material information that the company has a bona fide business purpose for preserving as confidential or iii render the company unable to comply with requirements under the securities act or exchange act the company may delay a demand registration hereunder only once in any period of twelve consecutive months if any registration is withdrawn or delayed pursuant to this clause b the company shall pay all expenses associated with such registration   c          if the holders initially requesting a demand registration elect to distribute the registrable securities covered by their request in an underwritten offering they shall so advise the company as a part of their request made pursuant to section a  and the company shall include such information in its notice to the other holders of registrable securities the company shall select the investment banking firm or firms to act as the managing underwriter or underwriters in connection with such offering provided  that such selection shall be subject to the consent of holders of a majority of the registrable securities which consent shall not be unreasonably withheld or delayed   d          if a demand registration involves an underwritten offering and the managing underwriter of the requested demand registration advises the company in writing that in its opinion the number of shares of common stock proposed to be included in the demand registration including all registrable securities and all other shares of common stock proposed to be included in such underwritten offering exceeds the number of shares of common stock which can be sold in such underwritten offering andor the number of shares of common stock proposed to be included in such registration would adversely affect the price per share of the registrable securities proposed to be sold in such underwritten offering the company shall include in such demand registration i first the number of shares of common stock that the holders propose to sell and ii second the number of shares of common stock proposed to be included therein by any other persons including shares of common stock to be sold for the account of the company andor other holders of common stock allocated among such persons in such manner as they may agree if the managing underwriter determines that less than all of the registrable securities held by holders proposed to be sold can be included in such offering then such registrable securities that can be included in such offering shall be allocated pro rata among the respective holders thereof on the basis of the number of registrable securities owned by each such holder                        piggyback registration    a          whenever the company proposes to register any shares of its common stock under the securities act other than a registration effected solely to implement an employee benefit plan or a transaction to which rule  of the securities act is applicable or a registration statement on form s s or any successor form thereto or another form not available for registering the registrable securities for sale to the public whether for its own account or for the account of one or more stockholders of the company and the form of registration statement to be used may be used for any registration of registrable securities a “ piggyback registration ” the company shall give prompt written notice in any event no later than ten  business days prior to the filing of such registration statement to the holders of the company’s intention to effect such a registration and subject to section b and section c  shall include in such registration all registrable securities that the holders have requested to be included within such registration provided to have its registrable securities included in such registration a holder must provide such request in writing to the company within three  business days after the company’s notice has been given to each such holder a piggyback registration shall not be considered a demand registration for purposes of section  of this addendum   b          if a piggyback registration is initiated as a primary underwritten offering on behalf of the company and the managing underwriter advises the company in writing that in its opinion the number of shares of common stock proposed to be included in such registration including all registrable securities if any holders of registrable securities have elected to include registrable securities in such piggyback registration and all other shares of common stock proposed to be included in such underwritten offering exceeds the number of shares of common stock which can be sold in such offering andor that the number of shares of common stock proposed to be included in any such registration would adversely affect the price per share of the common stock to be sold in such offering the company shall include in such registration i first the number of shares of common stock that the company proposes to sell ii second the number of shares of common stock if any requested to be included therein by holders allocated pro rata among all such holders on the basis of the number of registrable securities owned by each such holder or in such manner as they may otherwise agree and iii third the number of shares of common stock requested to be included therein by other holders of common stock other than holders allocated among such holders in such manner as they may agree   c          if a piggyback registration is initiated as an underwritten offering on behalf of a holder of common stock other than a holder and the managing underwriter advises the company in writing that in its opinion the number of shares of common stock proposed to be included in such registration including all registrable securities held by holders held by holders and all other shares of common stock proposed to be included in such underwritten offering exceeds the number of shares of common stock which can be sold in such offering andor that the number of shares of common stock proposed to be included in any such registration would adversely affect the price per share of the common stock to be sold in such offering the company shall include in such registration i first the number of shares of common stock requested to be included therein by the holders requesting such registration and by the holders allocated pro rata among all such stockholders on the basis of the number of shares of common stock on a fully diluted as converted basis and the number of registrable securities as applicable owned by all such stockholders or in such manner as they may otherwise agree and ii second the number of shares of common stock requested to be included therein by other holders of common stock allocated among such holders in such manner as they may agree            d          if any piggyback registration is initiated as a primary underwritten offering on behalf of the company the company shall select the investment banking firm or firms to act as the managing underwriter or underwriters in connection with such offering   e          notwithstanding anything contained herein to the contrary with respect to any piggyback registration that i occurs and is effective on or before december   and ii relates solely to the offering of shares of common stock or other capital securities the holder shall not request that any of its registrable securities be included in such registration               registration procedures  if and whenever holders request that any registrable securities be registered pursuant to the provisions of this addendum the company shall use its reasonable best efforts to effect the registration and the sale of such registrable securities in accordance with the intended method of disposition thereof and pursuant thereto the company shall as soon as reasonably practicable   a          subject to section a  prepare and file with the sec a registration statement with respect to such registrable securities and use its reasonable best efforts to cause such registration statement to become effective   b          prepare and file with the sec such amendments posteffective amendments and supplements to such registration statement and the prospectus used in connection therewith as may be necessary to keep such registration statement effective for a period of not less than ninety  days or if earlier until all of such registrable securities have been disposed of and to comply with the provisions of the securities act with respect to the disposition of such registrable securities in accordance with the intended methods of disposition set forth in such registration statement   c          at least five  business days before filing such registration statement prospectus or amendments or supplements thereto furnish to one counsel selected by holders of a majority of the registrable securities copies of such documents proposed to be filed which documents shall be subject to the review comment and approval of such counsel            d          notify each selling holder promptly after the company receives notice thereof of the time when such registration statement has been declared effective or a supplement to any prospectus forming a part of such registration statement has been filed   e          furnish to each selling holder such number of copies of the prospectus included in such registration statement including each preliminary prospectus and any supplement thereto in each case including all exhibits and documents incorporated by reference therein and such other documents as such seller may reasonably request in order to facilitate the disposition of the registrable securities owned by such holder   f          use its reasonable best efforts to register or qualify such registrable securities under such other securities or “blue sky” laws of such jurisdictions as any selling holder reasonably requests and do any and all other acts and things which may be reasonably necessary or advisable to enable such holders to consummate the disposition of such registrable securities in such jurisdictions provided  that the company shall not be required to qualify generally to do business subject itself to general taxation or consent to general service of process in any jurisdiction where it would not otherwise be required to do so but for this section     g          notify each selling holder at any time when a prospectus relating thereto is required to be delivered under the securities act of the occurrence of any event as a result of which the prospectus included in such registration statement contains an untrue statement of a material fact or omits any fact necessary to make the statements therein not misleading and at the request of any such holder the company shall prepare a supplement or amendment to such prospectus so that as thereafter delivered to the purchasers of such registrable securities such prospectus shall not contain an untrue statement of a material fact or omit to state any fact necessary to make the statements therein not misleading   h          make available for inspection by any selling holder any underwriter participating in any disposition pursuant to such registration statement and any attorney accountant or other agent retained by any such holder or underwriter collectively the “ inspectors ” all financial and other records pertinent corporate documents and properties of the company collectively the “ records ” and cause the company’s officers directors and employees to supply all information reasonably requested by any such inspector in connection with such registration statement provided  that such inspectors enter into a written reasonable and customary confidentiality agreement with the company   i          provide a transfer agent and registrar which may be the same entity for all such registrable securities not later than the effective date of such registration   j          use its reasonable best efforts to cause such registrable securities to be listed on each securities exchange on which the common stock is then listed or if the common stock is not then listed on a national securities exchange selected by the holders of a majority of such registrable securities            k          in connection with an underwritten offering enter into such customary agreements including underwriting and lockup agreements in customary form and take all such other customary actions as the holders or the managing underwriter of such offering reasonably request in order to expedite or facilitate the disposition of such registrable securities including without limitation making appropriate officers of the company available to participate in a “road show” and other customary marketing activities including oneonone meetings with prospective purchasers of the registrable securities provided  however  that the officers of the company shall not be required to be available for more than ten  business days during any twelve  month period for any “road show” marketing activities or oneonone meetings   l          otherwise use its reasonable best efforts to comply with all applicable rules and regulations of the sec and make available to its stockholders an earnings statement in a form that satisfies the provisions of section a of the securities act and rule  thereunder no later than thirty  days after the end of the month period beginning with the first day of the company’s first full fiscal quarter after the effective date of such registration statement which earnings statement shall cover said month period and which requirement will be deemed to be satisfied if the company timely files complete and accurate information on forms q k and k under the exchange act and otherwise complies with rule  under the securities act   m          furnish to each selling holder and each underwriter if any with i a legal opinion of the company’s outside counsel dated the effective date of such registration statement and if such registration includes an underwritten public offering dated the date of the closing under the underwriting agreement in form and substance as is customarily given in opinions of the company’s counsel to underwriters in underwritten public offerings and ii a “comfort” letter signed by the company’s independent certified public accountants in form and substance as is customarily given in accountants’ letters to underwriters in underwritten public offerings   n          without limiting section  above use its reasonable best efforts to cause such registrable securities to be registered with or approved by such other governmental agencies or authorities as may be necessary by virtue of the business and operations of the company to enable the holders to consummate the disposition of such registrable securities in accordance with their intended method of distribution thereof   o          notify the holders promptly of any request by the sec to amend or supplement such registration statement or prospectus or for additional information            p          notify the holders which notice shall be accompanied by an instruction to suspend the use of the prospectus until the requisite changes have been made as promptly as reasonably possible i of the issuance by the commission or any other federal or state governmental authority of any stop order suspending the effectiveness of a registration statement covering any or all of the registrable securities or the initiation of any proceedings for that purpose ii of the receipt by the company of any notification with respect to the suspension of the qualification or exemption from qualification of any of the registrable securities for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose iii of the occurrence of any event or passage of time that makes the financial statements included in a registration statement ineligible for inclusion therein or any statement made in a registration statement or prospectus or any document incorporated or deemed to be incorporated therein by reference untrue in any material respect or that requires any revisions to a registration statement prospectus or other documents so that in the case of a registration statement or the prospectus as the case may be it will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein in light of the circumstances under which they were made not misleading and iv of the occurrence or existence of any pending corporate development with respect to the company that the company believes may be material and that in the determination of the company makes it not in the best interest of the company to allow continued availability of a registration statement or prospectus provided  however  in no event shall any such notice contain any information which would constitute material nonpublic information regarding the company if the company notifies the holders in accordance with this paragraph to suspend the use of any registration statement or prospectus until the requisite changes to such registration statement or prospectus have been made then the holders shall suspend use of such registration statement or prospectus the company will use its commercially reasonable best efforts to prevent the issuance of any order suspending the effectiveness of a registration statement or prospectus and if any such order suspending the effectiveness of a registration statement or prospectus is issued shall promptly use its commercially reasonable best efforts to cause all stop orders to be withdrawn to update or correct any financial statements or other information contained in the registration statement or prospectus as the case may be and to otherwise ensure that the use of the registration statement or prospectus may be resumed as promptly as is practicable   q          permit any holder that in such holder’s sole and exclusive judgment might be deemed to be an underwriter or a controlling person of the company to participate in the preparation of such registration statement and to require the insertion therein of language furnished to the company in writing which in the reasonable judgment of such holder and its counsel should be included   r          otherwise use its reasonable best efforts to take all other steps necessary to effect the registration of such registrable securities contemplated hereby               expenses  all expenses other than selling expenses incurred by the company in complying with its obligations pursuant to this addendum and in connection with the registration and disposition of registrable securities including without limitation all registration and filing fees underwriting expenses other than fees omissions or discounts expenses of any audits incident to or required by any such registration fees and expenses of complying with securities and “blue sky” laws printing expenses reasonable fees and expenses of the company’s counsel and accountants and reasonable fees and expenses of one counsel for the holders participating in such registration as a group selected by holders of a majority of the registrable securities initially requesting such registration and in the case of all other registrations hereunder the holders of a majority of the registrable securities included in the registration shall be paid by the company all selling expenses relating to registrable securities held by holders and registered pursuant to this addendum shall be borne and paid by the holders of such registrable securities in proportion to the number of registrable securities registered for each such holder                         indemnification    a          the company shall indemnify and hold harmless to the fullest extent permitted by law each holder such holder’s officers directors managers members partners stockholders and affiliates each underwriter broker or any other person acting on behalf of such holder and each other person if any who controls any of the foregoing persons within the meaning of section  of the securities act or section  of the exchange act against all losses claims actions damages liabilities and expenses joint or several to which any of the foregoing persons may become subject under the securities act or otherwise insofar as such losses claims actions damages liabilities or expenses arise out of or are based upon any untrue or alleged untrue statement of a material fact contained in any registration statement prospectus preliminary prospectus free writing prospectus as defined in rule  promulgated under the securities act or any amendment thereof or supplement thereto or any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein not misleading or any violation or alleged violation by the company of the securities act or any other similar federal or state securities laws or any rule or regulation promulgated thereunder applicable to the company and relating to action or inaction required of the company in connection with any such registration qualification or compliance and shall reimburse such persons for any legal or other expenses reasonably incurred by any of them in connection with investigating or defending any such loss claim action damage or liability except insofar as the same are caused by or contained in any information furnished in writing to the company by such holder expressly for use therein or by such holder’s failure to deliver a copy of the registration statement prospectus freewriting prospectus as defined in rule  promulgated under the securities act or any amendments or supplements thereto if the same was required by applicable law to be so delivered after the company has furnished such holder with a sufficient number of copies of the same prior to any written confirmation of the sale of registrable securities   b          in connection with any registration in which a holder is participating each such holder shall furnish to the company in writing such information and affidavits as the company reasonably requests for use in connection with any such registration statement or prospectus and to the extent permitted by law such holder shall indemnify and hold harmless the company each director of the company each officer of the company who shall sign such registration statement each underwriter broker or other person acting on behalf of the holders and each person who controls any of the foregoing persons within the meaning of section  of the securities act or section  of the exchange act against any losses claims actions damages liabilities or expenses resulting from any untrue or alleged untrue statement of material fact contained in the registration statement prospectus preliminary prospectus free writing prospectus as defined in rule  promulgated under the securities act or any amendment thereof or supplement thereto or any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein not misleading but only to the extent that such untrue statement or omission is contained in any information or affidavit so furnished in writing by such holder provided  that the obligation to indemnify shall be several not joint and several for each holder and shall be limited to the net proceeds after underwriting fees commissions or discounts actually received by such holder from the sale of registrable securities pursuant to such registration statement            c          promptly after receipt by an indemnified party of notice of the commencement of any action involving a claim referred to in this section   such indemnified party shall if a claim in respect thereof is made against an indemnifying party give written notice to the latter of the commencement of such action the failure of any indemnified party to notify an indemnifying party of any such action shall not unless such failure shall have a material adverse effect on the indemnifying party relieve the indemnifying party from any liability in respect of such action that it may have to such indemnified party hereunder in case any such action is brought against an indemnified party the indemnifying party shall be entitled to participate in and to assume the defense of the claims in any such action that are subject or potentially subject to indemnification hereunder jointly with any other indemnifying party similarly notified to the extent that it may wish with counsel reasonably satisfactory to such indemnified party and after written notice from the indemnifying party to such indemnified party of its election so to assume the defense thereof the indemnifying party shall not be responsible for any legal or other expenses subsequently incurred by the indemnified party in connection with the defense thereof provided  that if i any indemnified party shall have reasonably concluded that there may be one or more legal or equitable defenses available to such indemnified party which are additional to or conflict with those available to the indemnifying party or that such claim or litigation involves or could have an effect upon matters beyond the scope of the indemnity provided hereunder or ii such action seeks an injunction or equitable relief against any indemnified party or involves actual or alleged criminal activity the indemnifying party shall not have the right to assume the defense of such action on behalf of such indemnified party without such indemnified party’s prior written consent but without such consent shall have the right to participate therein with counsel of its choice and such indemnifying party shall reimburse such indemnified party and any person controlling such indemnified party for that portion of the fees and expenses of any counsel retained by the indemnified party which is reasonably related to the matters covered by the indemnity provided hereunder if the indemnifying party is not entitled to or elects not to assume the defense of a claim it shall not be obligated to pay the fees and expenses of more than one counsel for all parties indemnified by such indemnifying party with respect to such claim unless in the reasonable judgment of any indemnified party a conflict of interest may exist between such indemnified party and any other of such indemnified parties with respect to such claim in such instance the conflicting indemnified parties shall have a right to retain one separate counsel chosen by the holders of a majority of the registrable securities included in the registration at the expense of the indemnifying party in no event will any indemnified party settle or compromise any claim for which it may seek indemnification hereunder without the prior written consent of the indemnifying party which consent shall not be unreasonably withheld            d          if the indemnification provided for hereunder is held by a court of competent jurisdiction to be unavailable to an indemnified party with respect to any loss claim damage liability or action referred to herein then the indemnifying party in lieu of indemnifying such indemnified party hereunder shall contribute to the amounts paid or payable by such indemnified party as a result of such loss claim damage liability or action in such proportion as is appropriate to reflect the relative fault of the indemnifying party on the one hand and of the indemnified party on the other in connection with the statements or omissions which resulted in such loss claim damage liability or action as well as any other relevant equitable considerations provided  that the maximum amount of liability in respect of such contribution shall be limited in the case of each holder to an amount equal to the net proceeds after underwriting fees commissions or discounts actually received by such holder from the sale of registrable securities effected pursuant to such registration the relative fault of the indemnifying party and of the indemnified party shall be determined by reference to among other things whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the indemnifying party or by the indemnified party and the parties’ relative intent knowledge access to information and opportunity to correct or prevent such statement or omission the parties agree that it would not be just and equitable if contribution pursuant hereto were determined by pro rata allocation or by any other method or allocation which does not take account of the equitable considerations referred to herein no person guilty or liable of fraudulent misrepresentation shall be entitled to contribution from any person               participation in underwritten registrations  no person may participate in any registration hereunder which is underwritten unless such person i agrees to sell such person’s securities on the basis provided in any underwriting arrangements approved by the person or persons entitled hereunder to approve such arrangements and ii completes and executes all questionnaires powers of attorney indemnities underwriting agreements and other documents required under the terms of such underwriting arrangements provided  that in connection with any underwritten registration no holder shall be required to make any representations or warranties to the company or the underwriters other than representations and warranties regarding such holder such holder’s ownership of its shares of common stock to be sold in the offering and such holder’s intended method of distribution or to undertake any indemnification obligations to the company or the underwriters with respect thereto except as otherwise provided in section                 rule  compliance  with a view to making available to the holders the benefits of rule  under the securities act and any other rule or regulation of the sec that may at any time permit a holder to sell securities of the company to the public without registration or pursuant to a registration on form s or any successor form the company shall   a          make and keep public information available as those terms are understood and defined in rule  under the securities act at all times after the registration date            b          use reasonable best efforts to file with the sec in a timely manner all reports and other documents required of the company under the securities act and the exchange act and   c          furnish to any holder so long as the holder owns registrable securities promptly upon request a written statement by the company as to its compliance with the reporting requirements of rule  under the securities act and of the securities act and the exchange act a copy of the most recent annual or quarterly report of the company and such other reports and documents so filed or furnished by the company as such holder may reasonably request in connection with the sale of registrable securities without registration             preservation of rights  the company shall not i grant any registration rights to third parties which are more favorable than or inconsistent with the rights granted hereunder or ii enter into any agreement take any action or permit any change to occur with respect to its securities that violates or subordinates the rights expressly granted to the holders of registrable securities in this addendum             termination  the terms and provisions of this addendum shall be of no further force or effect upon the earlier to occur of i when there shall no longer be any registrable securities outstanding and ii the date that is  years after the expiration of the exercise period as defined in the warrant provided  that the provisions of section  and section  shall survive any such termination             existing shelf  notwithstanding anything contained herein to the contrary in no event shall any holder be entitled to have any registrable securities included in any prospectus supplement or posteffective amendment to the company’s existing registration statement on form s sec file no           perceptive credit opportunities fund qp lp  pooled investment fund edelman formdscom  sec filings of fundraisings and investments in hedge funds private equity firms startups and growing companies formdscom newest filter local perceptive credit opportunities fund qp lp industry pooled investment fund see others in industry address co perceptive advisors llc  astor place  th floor new york ny phone  filings date filingtype reported sold incremental cash type exemptions link to raw filing  new   other b c c c sec link directors and executives current and past name role joseph edelman executive na perceptive credit opportunities gp llc executive   kadmon holdings k apr    am  seeking alphasign in  join nowgo»kadmon holdings kdmnform k  current reportapr    amabout kadmon holdings kdmnview as pdf kadmon holdings inc form k received   ﻿ united states securities and exchange commission washington dc      form k     current report pursuant to section  or d of the securities exchange act of  date of report date of earliest event reported    april    march          kadmon holdings  inc exact name of registrant as specified in its charter       ﻿                   delaware          state or other jurisdiction of incorporation   commission file number   irs employer identification no      east  th street new  york ny    address of principal executive offices   zip code registrant’s telephone number including area code        na former name or former address if changed since last report     check the appropriate box below if the form k filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions   ☐ written communications pursuant to rule  under the securities act  cfr    ☐ soliciting material pursuant to rule a under the exchange act  cfr a   ☐ precommencement communications pursuant to rule db under the exchange act  cfr db   ﻿   ☐ precommencement communications pursuant to rule ec under the exchange act  cfr ec ﻿       item  entry into a material definitive agreement ﻿ on march   kadmon holdings inc the “company” and the lenders party thereto entered into amendment no  the “third amendment” to the third amended and restated convertible  credit agreement dated as of august   the “ credit agreement”  under the terms of the third amendment principal payments owed under the  credit agreement in the amount of  per month have been deferred until january    additionally the parties amended a future capital raising covenant pursuant to which the company was required to raise  million through the sale of qualified equity interests by extending the time period by which the company is required to raise the remaining  million of capital by six months from june   to december    all other material terms of the  credit agreement remain the same  the third amendment also amends certain terms of the warrants to purchase an aggregate of  shares of the company’s common stock issued in connection with the  credit agreement the “ warrants”  pursuant to the third amendment the warrants may now only be exercised for cash and the exercise price was reduced from  per share to  per share  the redemption feature in the  warrants was also amended such that the warrant holder may demand a redemption of the warrant shares upon the occurrence of and during the continuance of an event of default  prior to this amendment the warrant could be redeemed by the warrant holder at any time after the  st month  as amended if these warrants are exercised the company will receive approximately  million in proceeds the lenders party to the  credit agreement and the third amendment or their affiliates are significant stockholders of the company  in addition perceptive life sciences master fund ltd an affiliate of perceptive credit holdings lp participated in the company’s march  private placement the foregoing summary of the third amendment is not complete and is qualified in its entirety by reference to the full and complete text of the third amendment a copy of which is attached as exhibit  to this current report on form k which is incorporated herein by reference ﻿ item  creation of a direct financial obligation or an obligation under an offbalance sheet   arrangement of a registrant      the information included in item  above is incorporated by reference into this item  item  other events on april    the company issued a press release announcing the third amendment  a copy of the press release is filed as exhibit   to this current report on form k and is incorporated herein by reference item  financial statements and exhibits d exhibits   ﻿     ﻿     exhibit no   description ﻿   ﻿   ﻿       amendment   to credit agreement dated march        by and among kadmon pharmaceuticals llc the guarantors from time to time party thereto the lenders from time to time party thereto and perceptive credit holdings lp         press release of kadmon holdings inc dated april   ﻿ ﻿ ﻿   ﻿ ﻿ ﻿ signature pursuant to the requirements of the securities exchange act of  the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized   ﻿                           kadmon holdings inc       date april            s konstantin poukalov         konstantin poukalov         executive vice president chief financial officer ﻿ ﻿   exhibit    execution version ﻿ amendment  to credit agreement and amendment to warrant certificates ﻿ this amendment  to credit agreement and amendment to warrant certificates dated as of march    this “ third   amendment ” is made among kadmon pharmaceuticals llc    a   pennsylvania   limited   liability   company   the   “ borrower ” certain affiliates of the borrower listed on the signature pages hereof under the heading “guarantors” each a “ guarantor ” and collectively the “guarantors” and the lenders listed on the signature pages hereof under the heading “lenders” each a “ lender ” and collectively the “ lenders ” with respect to the credit agreement referred to below  recitals whereas the borrower the guarantors and the   lenders   are parties to a credit   agreement   dated   as of   august   as subsequently amended or otherwise modified including pursuant to this third amendment the   “ credit   agreement ” ﻿ whereas in connection with the making of the loans under the credit agreement the borrower executed and issued warrant certificates as defined in the credit agreement to the lenders which warrant certificates were originally issued on august   and in connection with the amendment and restatement thereof were reissued on december   ﻿ whereas   on the terms and subject to the conditions set forth herein the parties   hereto desire   to amend the existing credit   agreement defined below as set   forth   herein and ﻿ whereas on the terms and subject to the conditions set forth herein the parties also desire to amend the existing warrant certificates defined below as set forth herein ﻿ now   therefore in consideration of   the   mutual agreements   provisions   and   covenants   contained herein the parties hereto agree as   follows ﻿ section  definitions interpretation  a terms defined andor used in credit agreement      all capitalized terms used in this third amendment including   in the preamble and recitals hereof and   not otherwise defined herein shall have the   meanings   assigned to them in the credit agreement b terms defined in this third amendment   the following terms when used in this third amendment shall have the following meanings such meanings to be equally applicable to the singular and plural forms thereof “ borrower ” is defined in the preamble    “ credit agreement ” is defined in the first recital  “ existing credit agreement ” means the credit agreement as in effect immediately prior to the third amendment effective date “ existing warrant certificate ” means any warrant certificate as in effect immediately prior to the third amendment effective date “ guarantor ” is defined in the preamble  “ third amendment ” is defined in the preamble  “ third amendment effective date ” is defined in section   c interpretation   the rules of interpretation set forth in section      and  of the credit   agreement shall be applicable to this third amendment   and are incorporated herein by   this reference section  amendments to existing credit agreement      e ffective as of and subject to the occurrence of the third amendment effective date the existing credit agreement is hereby amended as follows a section  of the existing credit agreement is hereby amended by adding the following defined terms in their alphabetically appropriate places “ excluded asset sale ” means any asset sale permitted pursuant to i clauses a through h of section  and ii to the extent but only to the extent x such asset sale is consummated during the period from the third amendment effective date to december   and y is permitted pursuant to the proviso to section bi    clause j of section   “ third amendment ” means amendment  to the credit agreement dated as of march      made among the borrower the guarantors parties thereto and the lenders parties thereto ﻿ “ third amendment effective date ” means march    the date the parties hereto mutually agree that the third amendment became effective  b section  of the existing credit agreement is hereby further amended by amending and restating in its entirety the definition of “ warrant certificate ” set forth therein to read as follows “ warrant certificate ” means each warrant certificate substantially in the form of exhibit i  executed and delivered by holdings in favor of a lender pursuant to section giv  as any such certificate may be subsequently amended replaced substituted or otherwise modified    c section a of the existing credit agreement is hereby amended in its entirety and to read as follows “ repayment   until the payment date occurring on january   no payments of principal of the loans shall be due  commencing with such payment date and on each payment date occurring thereafter the borrower shall repay the outstanding principal of the loans at par in an amount equal to  by paying to each lender its proportionate share of such amount on such payment date  to the extent not previously paid the outstanding principal amount of the loans together with all other outstanding obligations shall be due and payable on the maturity date” ﻿ d section bi of the existing credit agreement hereby amended in its entirety to read as follows “ asset sales  in the event of any contemplated asset sale or series of asset sales yielding net proceeds which when aggregated with the net proceeds of all other asset sales other than any excluded asset sale made after the date hereof exceed  borrower shall make a mandatory prepayment in respect of the loans as follows x if the assets sold represent substantially all of the assets or revenues of borrower or represent the sale of all or substantially all of the assets or revenues of any specific line of business which either on its own or together with other lines of business sold over the term of this agreement account for revenue generated by such lines of business exceeding  of the revenue of borrower in the immediately preceding year borrower shall make a mandatory prepayment of the loans in an amount equal to the redemption price for all loans applicable on the date of such asset sale y in the case of any asset sale permitted under section i  borrower shall make a mandatory prepayment of the loans in an amount equal to  of the net proceeds of such asset sale which amount shall be applied to the redemption price applicable on the date of such asset sale and z in the case of all other asset sales not described in the foregoing clauses x and y  borrower shall make a mandatory prepayment of the loans in an amount equal to the entire amount of the net proceeds of such asset sale which amount shall be applied to the redemption price applicable on the date of such asset sale credited in all cases described in clauses x y and z above in the order set forth in section bv e section j of the existing credit agreement is hereby amended in its entirety to read as follows “asset sales that x are not otherwise described in this section  and y are in respect of assets or properties that  if sold or otherwise disposed of during the period from the third amendment effective date to december   have a fair market value that does not exceed  in the aggregate for all properties and assets sold or otherwise disposed of during such period and  if sold or otherwise disposed of at any other time have a fair market value that does not exceed  in the aggregate for all assets or properties sold or    disposed of since the closing date exclusive of assets or properties sold or otherwise disposed of during the period described in clause y above” f section  of the existing credit agreement is hereby amended in its entirety to read as follows “future capital raising  during the period commencing with the third amendment effective date and ending on december    holdings shall have received an aggregate amount not less than  from a gross cash proceeds resulting from one or more sales offerings or issuances of its qualified equity interests b gross cash proceeds resulting from nondilutive funding from or arising out of one or more strategic transactions  eg licensing deal business development transaction etc entered into after the third amendment effective date but on or prior to december   and approved by the board of directors of holdings or c cash net proceeds from one or more asset sales permitted pursuant to section j ” ﻿ section  amendments to existing warrant certificates   e ffective as of and subject to the occurrence of the third amendment effective date each outstanding existing warrant certificate is hereby amended as follows  a section  of each existing warrant certificate is hereby amended by amending and restating the definitions of “ exercise price ” and “ rule  ” in their respective entireties to read as follows ﻿ “ exercise price ” means subject to adjustment pursuant to sections a and bi  a price per warrant share equal to  “ rule  ” means rule  under the securities act as amended b section     of each existing warrant certificate is hereby further amended by deleting the defined term “cashless exercise” ﻿ c section b of each existing warrant certificate is hereby amended and restated in its entirety to read as follows ﻿ “b        payment of the aggregate exercise price     when due and payable hereunder the holder shall pay the aggregate exercise price to the company by delivery of a certified or official bank check payable to the order of the company or by wire transfer of immediately available funds to an account designated in writing by the company” d section  of each existing warrant certificate is hereby amended by amending and restating the first paragraph of such section in its entirety to read as follow s ﻿ “upon the occurrence and during the continuance of any event of default at the option of the holder exercised by way of delivery of written notice to the company a “ redemption notice ” the holder shall have the right to terminate this warrant    certificate and demand a redemption of the warrant shares representing the then unexercised portion of this warrant certificate an “ early redemption ”” ﻿ section  conditions of effectiveness   this third amendment shall become effective upon and shall be subject to the prior or simultaneous satisfaction of each of the following conditions in a manner reasonably satisfactory to the lenders the date when all such conditions are so satisfied being the “ third amendment effective date ” a the lenders shall have received counterparts of this third amendment executed on behalf of the borrower guarantors and all lenders ﻿ b the representations warranties and reaffirmations set forth in section  below shall be true and correct ﻿ c the lenders shall have received all fees costs and expenses due and payable pursuant to section aiz of the credit agreement including without limitation the reasonable fees and expenses of morrison  foerster llp counsel to the lenders if then invoiced together with all other fees separately agreed to by the borrower and the lenders ﻿ d all legal matters incident to the effectiveness of this third amendment shall be reasonably satisfactory to the lenders ﻿ section  representations and warranties reaffirmation   a the obligors hereby jointly and severally represent and warrant to each lender as follows i each obligor has full power authority and legal right to make and perform this third amendment  this third amendment is within each obligor’s corporate powers and has been duly authorized by all necessary corporate and if required by all necessary shareholder action  this third amendment has been duly executed and delivered by each obligor and each of this third amendment and the credit agreement as amended hereby and each other loan document to which such obligor is a party constitutes a legal valid and binding obligation of such obligor enforceable against each obligor in accordance with its terms except as such enforceability may be limited by a bankruptcy insolvency reorganization moratorium or similar laws of general applicability affecting the enforcement of creditors’ rights and b the application of general principles of equity regardless of whether such enforceability is considered in a proceeding in equity or at law  neither this third amendment nor the credit agreement x requires any consent or approval of registration or any other action by any governmental authority or any third party except for such as have been obtained or made and are in full force and effect y violates any applicable law or the charter bylaws or other organizational documents of any obligor or any of its subsidiaries or any order of any governmental authority other than any such violations that individually or in the aggregate could not reasonably be expected to have a material adverse effect or z violates or would reasonably be expected to result in an event of default under any material agreement binding    upon such obligor or any of its subsidiaries or assets or give rise to a right thereunder to require any payment to be made by any such person ii the representations and warranties set forth in each loan document in each case are true and correct in all material respects with the same effect as if then made unless stated to relate solely to an earlier date in which case such representations and warranties shall be true and correct in all material respects as of such earlier date iii no default or event of default has occurred or is continuing or will result after giving effect to this third amendment  b each obligor hereby ratifies confirms reaffirms and acknowledges its obligations under each loan document including without limitation the credit agreement to which it is a party and agrees that each such loan document remains in full force and effect undiminished by this third amendment except as expressly provided herein provided that after the third amendment effective date all references in any loan document to the “credit agreement” “loan document” “thereunder” “thereof” or words of similar import shall mean the existing credit agreement and the loan documents as amended or otherwise modified by this third amendment  by executing this third amendment each obligor acknowledges that it has read consulted with its attorneys regarding and understands this third amendment section  guarantors’ acknowledgement and consent   each guarantor has read this third amendment and consents to the terms hereof and hereby acknowledges and agrees that any loan document to which such person is a party shall continue in full force and effect and that all of its obligations thereunder shall be valid binding and enforceable except as enforceability may be limited by bankruptcy insolvency reorganization moratorium or similar laws relating to or limiting creditors’ rights generally and by equitable principles relating to enforceability and shall not be impaired or limited by the execution or effectiveness of this third amendment  each guarantor acknowledges and agrees that i such person is not required by the terms of the credit agreement or any other loan document to consent to the supplements and amendments to the credit agreement effected pursuant to this third amendment and ii nothing in the credit agreement this third amendment or any other loan document shall be deemed to require the consent of such person to any future supplements or amendments to the credit agreement section  miscellaneous  a no waiver   nothing contained herein shall be deemed to constitute a waiver of compliance with any term or condition contained in the existing credit agreement the credit agreement or any of the other loan documents or constitute a course of conduct or dealing among the parties  except as expressly stated herein the lenders reserve all rights privileges and remedies under the loan documents  except as expressly amended hereby the credit agreement and other loan documents remain unmodified and in full force and effect b severability   in case any provision of or obligation under this third amendment shall be invalid illegal or unenforceable in any jurisdiction the validity legality and    enforceability of the remaining provisions or obligations or of such provision or obligation in any other jurisdiction shall not in any way be affected or impaired thereby c headings   headings and captions used in this third amendment including the exhibits schedules and annexes hereto if any are included for convenience of reference only and shall not be given any substantive effect d integration   this third amendment constitutes a loan document and together with the other loan documents incorporates all negotiations of the parties hereto with respect to the subject matter hereof and is the final expression and agreement of the parties hereto with respect to the subject matter hereof  this third amendment shall unless otherwise expressly indicated therein be construed administered and applied in accordance with all of the terms and provisions of the credit agreement including section  thereof including without limitation sections      and   e this third amendment shall be binding upon and inure to the benefit of the parties hereto and their respective successors and permitted assigns f counterparts   this third amendment may be executed in any number of counterparts all of which taken together shall constitute one and the same instrument and any of the parties hereto may execute this third amendment by signing any such counterpart g controlling provisions   in the event of any inconsistencies between the provisions of this third amendment and the provisions of any other loan document the provisions of this third amendment shall govern and prevail  except as expressly modified by this third amendment the loan documents shall not be modified and shall remain in full force and effect in witness whereof the parties hereto have duly executed this third amendment as of the date first above written borrower ﻿ ﻿ kadmon pharmaceuticals llc ﻿ by  harlan w waksal president and chief executive officer ﻿ ﻿ guarantors ﻿ ﻿ kadmon corporation llc ﻿ by     harlan w waksal president and chief executive officer ﻿ ﻿ kadmon holdings inc fka kadmon holdings llc ﻿ by  harlan w waksal president and chief executive officer ﻿ ﻿ kadmon research institute llc ﻿ by  harlan w waksal president and chief executive officer ﻿ ﻿ three rivers research institute i llc ﻿ by  harlan w waksal president and chief executive officer    three rivers biologics llc ﻿ by  harlan w waksal president and chief executive officer ﻿ ﻿ three rivers global pharma llc ﻿ by  harlan w waksal president and chief executive officer ﻿    collateral representative ﻿ ﻿ perceptive credit holdings lp by perceptive credit opportunities gp llc its general partner ﻿ by  sandeep dixit chief credit officer ﻿ by  name title ﻿    lenders ﻿ ﻿ perceptive credit holdings lp by perceptive credit opportunities gp llc its general partner ﻿ by  sandeep dixit chief credit officer ﻿ by  name title ﻿    goldentree credit opportunities lp by goldentree asset management lp ﻿ by  name title ﻿ goldentree credit opportunities ltd by goldentree asset management lp ﻿ by  name title ﻿ goldentree insurance fund series interests of the sali multiseries fund lpby goldentree asset management lp by goldentree asset management lp ﻿ by  name title ﻿ gt nm lp by goldentree asset management lp ﻿ by  name title ﻿ san bernardino county employees’ retirement association by goldentree asset management lp ﻿ by  name title ﻿ ﻿ ﻿  exhibit  click to enlarge ﻿ kadmon announces amendment to credit agreement and related warrants new york april   — kadmon holdings inc nyse kdmn “kadmon” or the “company” today announced that the company together with its lending syndicate led by perceptive credit opportunities fund entered into an amendment to its  credit agreement and related warrants  terms of the amendment include but are not limited to · deferring the capital raise requirement of  million from june   to december    additionally proceeds from nondilutive funding sources such as business development transactions may be counted toward this capital raise · deferring mandatory monthly principal payments until january   and · amending  previously issued warrants to cash warrants and adjusting the warrant strike price to   “we are pleased to work with our lenders led by perceptive   credit opportunities fund to enter into this amendment which enables us to continue to focus our resources toward advancing our pipeline of promising clinical and preclinical product candidates” said harlan w waksal md president and ceo at kadmon    about kadmon holdings inc kadmon holdings inc is a fully integrated biopharmaceutical company developing innovative products for significant unmet medical needs we have a diversified product pipeline in autoimmune and fibrotic diseases oncology and genetic diseases forwardlooking statements this press release contains forwardlooking statements such statements may be preceded by the words “may” “will” “should” “expects” “plans” “anticipates” “could” “intends” “targets” “projects” “contemplates” “believes” “estimates” “predicts” “potential” or “continue” or the negative of these terms or other similar expressions forwardlooking statements involve known and unknown risks uncertainties and other important factors that may cause our actual results performance or achievements to be materially different from any future results performance or achievements expressed or implied by the forwardlooking statements we believe that these factors include but are not limited to i the initiation timing progress and results of our preclinical studies and clinical trials and our research and development programs ii our ability to advance product candidates into and successfully complete clinical trials iii our reliance on the success of our product candidates iv the timing or likelihood of regulatory filings and approvals v our ability to expand our sales and marketing capabilities vi the commercialization of our product candidates if approved vii  the pricing and reimbursement of our product candidates if approved viii the implementation of our business model strategic plans for our business product candidates and technology ix the scope of protection we are able to establish and maintain for intellectual property rights covering our product candidates and technology x our ability to operate our business without infringing the intellectual property rights and   proprietary technology of third parties xi costs associated with defending intellectual property infringement product liability and other claims xii regulatory developments in the united states europe and other jurisdictions xiii estimates of our expenses future revenues capital requirements and our needs for additional financing xiv the potential benefits of strategic collaboration agreements and our ability to enter into strategic arrangements xv our ability to maintain and establish collaborations or obtain additional grant funding xvi the rate and degree of market acceptance of our product candidates xvii developments relating to our competitors and our industry including competing therapies xviii our ability to effectively manage our anticipated growth xix our ability to attract and retain qualified employees and key personnel xx our ability to achieve cost savings and other benefits from our efforts to streamline our operations and to not harm our business with such efforts and xxi the use of proceeds from our recent private placement more detailed information about kadmon and the risk factors that may affect the realization of forwardlooking statements is set forth in the companys filings with the us securities and exchange commission sec including the companys annual report on form k filed pursuant to section  of the securities exchange act of  as amended with the sec on march   investors and security holders are urged to read these documents free of charge on the secs web site at wwwsecgov the company assumes no obligation to publicly update or revise its forwardlooking statements as a result of new information future events or otherwise ﻿ contact information ellen tremaine investor relations  ellentremainekadmoncom maeve conneighton  maeveargotpartnerscom ﻿  bizapediacom  human validation companiespeopleproductsservicestrademarksaddressesphone book our system has detected a high number of page requests from your ip address please prove to us that you are a human to continue using our website please send me to the search subscription offer page after i successfully answer the word challenge bizapediapro searchperform unlimited searches via ouradvanced search form withbizapedia pro searchfind out more bizapediapro databuild custom data listsfor one or many stateswith bizapedia pro datafind out more  copyright   · bizapediacom · all rights reservedblogpro searchpro apicontact usterms of useprivacy policysitemapdesktop version perceptive advisors graypools sign in learn more perceptive advisors fund manager institutional investors fund managers perceptive advisors perceptive advisors is a delaware fund manager located in new york new york it was registered on monday october    astor place new york new york  united states phone   httpwwwperceptivelifecom chief operating officer and chief compliance officer james mannix chief financial officer peter fierro managing member joseph edelman chief executive officer and portfolio manager joseph edelman inception date jurisdictiondelaware updated  as of date latest filing sec number crd number inception legal nameperceptive advisors llc nameperceptive advisors cik legal entity typelimited liability company ein holdings puts calls long positions statements employees regulatory aum plans pensions  welfare plans  funds private equity funds  hedge funds  puts  securityvalue radius health inc rdus k calls  securityvalue axovant sciences ltd axon m sage therapeutics inc sage m evolent health inc evh k long positions  securityvalue neurocrine biosciences inc nbix m global blood therapeutics inc gbt m amicus therapeutics inc fold m versartis inc vsar m la jolla pharmaceutical co ljpc m alnylam pharmaceuticals inc alny m sarepta therapeutics inc srpt m retrophin inc rtrx m nxstage medical inc nxtm m xencor inc xncr m aclaris therapeutics inc acrs m tesaro inc tsro m vbi vaccines inc vbiv m radius health inc rdus m avexis inc avxs m evolent health inc evh m vertex pharmaceuticals inc  ma vrtx m regenxbio inc rgnx m lion biotechnologies inc lbio m cytomx therapeutics inc ctmx m anaptysbio inc anab m zogenix inc zgnx m ardelyx inc ardx m galapagos nv m dbv technologies s a m quotient ltd qtnt m nevro corp nvro m kadmon holdings inc kdmn m blueprint medicines corp bpmc m wave life sciences ltd wve m acceleron pharma inc xlrn m acelrx pharmaceuticals inc acrx m assembly biosciences inc asmb m avadel pharmaceuticals plc avdl m aldeyra therapeutics inc aldx m amag pharmaceuticals inc amag m ani pharmaceuticals inc anip m corium international inc cori m abiomed inc abmd m corbus pharmaceuticals holdings inc crbp m irhythm technologies inc irtc m clovis oncology inc clvs m biorad laboratories inc m exact sciences corp exas m antares pharma inc atrs m myokardia inc myok m capital senior living corp csu m alder biopharmaceuticals inc aldr m ani pharms inc sr note m forward pharma as m uniqure nv qure m minerva neurosciences inc nerv m foamix pharmaceuticals ltd fomx m cidara therapeutics inc cdtx m viveve medical inc m humana inc hum m sierra oncology inc srra m clearside biomedical inc clsd m invitae corp nvta m pfenex inc pfnx m zynerba pharmaceuticals inc zyne m axovant sciences ltd axon m neptune technologies  bioressources inc nept m synergy pharmaceuticals inc sgyp m jazz pharmaceuticals jazz m peregrine pharmaceuticals inc  m dermira inc derm m psivida corp psdv m abeona therapeutics cw m adma biologics inc m amgen inc amgn m oncobiologics inc ons m abeona therapeutics inc abeo m histogenics corp hsgx m aveo pharmaceuticals inc aveo m xenon pharmaceuticals inc xene m ocera therapeutics inc m mgc diagnostics corp mgcd m aerie pharmaceuticals inc aeri m portola pharmaceuticals inc ptla m alliqua biomedical inc alqa m unitedhealth group inc unh m ra pharmaceuticals inc rarx m selecta biosciences inc selb m immunomedics inc immu m eiger biopharmaceuticals inc eigr m brainstorm cell therapeutics inc shares old m affimed nv m arrowhead research corporation arwr m curis inc cris m champions oncology inc csbr m bellicum pharmaceuticals inc blcm m exelixis inc exel m akorn inc akrx k zosano pharma corp zsan k azurrx biopharma inc azrx k incyte corp incy k wellcare health plans inc wcg k fiat chrysler automobiles nv k lantheus holdings inc lnth k metastat inc mtst k heska corp hska k orasure technologies inc osur k illumina inc ilmn k achaogen inc akao k proteon therapeutics inc prto k hillrom holdings inc hrc k masimo corp masi k centene corp cnc k allscripts healthcare solutions inc mdrx k pra health sciences inc prah k hms holdings corp hmsy k mckesson corp mck k cambrex corp cbm k phibro animal health corp pahc k quality systems inc qsii k anthem inc antm k vanda pharmaceuticals inc vnda k cutera inc cutr k ferrari n v k akebia therapeutics inc akba k bluebird bio inc blue k oncobiologics inc wts k auris me k pernix therapeutics holdings k quorum health corp qhc k lhc group inc lhcg k arno therapeutics inc arni k acasti pharma inc acst k oncobiologics inc wts k array biopharma inc arry k audentes therapeutics inc bold k ignyta inc rxdx k r rcm inc k aeglea biotherapeutics inc agle k celldex therapeutics inc cldx k abbvie inc abbv k china biologic products inc cbpo k biomarin pharmaceutical inc bmrn k epizyme inc epzm k abbott laboratories abt k peregrine pharmaceuticals pphm k agenus inc agen k capricor therapeutics inc capr k west pharmaceutical services inc wst k alcobra ltd k sevion therapeutics inc k cascadian therapeutics inc casc k therapeuticsmd inc txmd k five prime therapeutics inc fprx k ophthotech corp opht k cerus corp cers k tengion inc k cryolife inc cry k aevi genomic medicine inc gnmx k credit suisse nassau brh k aptevo therapeutics inc apvo k atricure inc atrc k allon therapeutics none ishares none ishares none ishares tr none boston scientific corp bsx none tracon pharmaceuticals inc tcon none obalon therapeutics inc obln none agile therapeutics inc agrx none danaher corp dhr none acadia healthcare company inc achc none    employees       regulatory assets under management b b b pensions  perceptive advisors llc pension plan new york welfare plans  perceptive advisors llc welfare benef new york private equity funds  perceptive credit opportunities fund lp delaware pcof phoenix ii fund lp delaware perceptive credit opportunities fund qp lp delaware pcof phoenix ii offshore fund lp cayman islands perceptive credit opportunities offshore fund lp cayman islands hedge funds  perceptive life sciences offshore fund ltd cayman islands perceptive life sciences qualified fund lp delaware perceptive life sciences fund lp delaware perceptive life sciences master fund ltd kentucky about  entities  legal   graypools llc kadmon holdings inc form b received   ﻿   prospectus supplement no  to prospectus dated july   filed pursuant to rule b registration no  ﻿ offering prospectus  shares of common stock ﻿ this prospectus supplement updates and supplements the prospectus dated july   the “prospectus” which forms a part of our registration statement on form s registration no  the “registration statement” this prospectus supplement is being filed to update and supplement the information in the prospectus with the information contained in our current report s on form k filed with the securities and exchange commission the “commission” on april    and april   the “current report s ” accordingly we have attached the current report s to this prospectus supplement this prospectus supplement relates to the offer and sale of  shares of our common stock par value  per share by the existing holders of the securities named in the prospectus this prospectus supplement should be read in conjunction with the prospectus which is to be delivered with this prospectus supplement this prospectus supplement updates and supplements the information in the prospectus if there is any inconsistency between the information in the prospectus and this prospectus supplement you should rely on the information in this prospectus supplement our common stock is quoted on the new york stock exchange under the trading symbol “kdmn” on march      the last reported sale price of our common stock was   per share ﻿ investing in our securities involves a high degree of risk you should review carefully the risks and uncertainties described under the heading “risk factors” beginning on page  of the prospectus and beginning on page  of our   annual report on form  k filed with the commission on march    and under similar headings in any further amendments or supplements to the prospectus before you decide whether to invest in our securities ﻿ neither the commission nor any state securities commission has approved or disapproved of these securities or determined if the prospectus or this prospectus supplement is truthful or complete any representation to the contrary is a criminal offense ﻿ the date of this prospectus supplement is april     ﻿   ﻿ united states securities and exchange commission washington dc      form k     current report pursuant to section  or d of the securities exchange act of  date of report date of earliest event reported april   march       kadmon holdings inc exact name of registrant as specified in its charter       ﻿                   delaware       state or other jurisdiction of incorporation   commission file number   irs employer identification no      east  th street new  york ny    address of principal executive offices   zip code registrant’s telephone number including area code   na former name or former address if changed since last report     check the appropriate box below if the form k filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions   ☐ written communications pursuant to rule  under the securities act  cfr    ﻿   ☐ soliciting material pursuant to rule a under the exchange act  cfr a   ☐ precommencement communications pursuant to rule db under the exchange act  cfr db   ﻿   ☐ precommencement communications pursuant to rule ec under the exchange act  cfr ec ﻿     item  entry into a material definitive agreement ﻿ on march   kadmon holdings inc the “company” and the lenders party thereto entered into amendment no  the “third amendment” to the third amended and restated convertible  credit agreement dated as of august   the “ credit agreement”  under the terms of the third amendment principal payments owed under the  credit agreement in the amount of  per month have been deferred until january    additionally the parties amended a future capital raising covenant pursuant to which the company was required to raise  million through the sale of qualified equity interests by extending the time period by which the company is required to raise the remaining  million of capital by six months from june   to december    all other material terms of the  credit agreement remain the same  the third amendment also amends certain terms of the warrants to purchase an aggregate of  shares of the company’s common stock issued in connection with the  credit agreement the “ warrants”  pursuant to the third amendment the warrants may now only be exercised for cash and the exercise price was reduced from  per share to  per share  the redemption feature in the  warrants was also amended such that the warrant holder may demand a redemption of the warrant shares upon the occurrence of and during the continuance of an event of default  prior to this amendment the warrant could be redeemed by the warrant holder at any time after the  st month  as amended if these warrants are exercised the company will receive approximately  million in proceeds the lenders party to the  credit agreement and the third amendment or their affiliates are significant stockholders of the company  in addition perceptive life sciences master fund ltd an affiliate of perceptive credit holdings lp participated in the company’s march  private placement the foregoing summary of the third amendment is not complete and is qualified in its entirety by reference to the full and complete text of the third amendment a copy of which is attached as exhibit  to this current report on form k which is incorporated herein by reference ﻿ item  creation of a direct financial obligation or an obligation under an offbalance sheet arrangement of a registrant      the information included in item  above is incorporated by reference into this item  item  other events on april   the company issued a press release announcing the third amendment a copy of the press release is filed as exhibit  to this current report on form k and is incorporated herein by reference item  financial statements and exhibits d exhibits   ﻿     ﻿     exhibit no   description ﻿   ﻿   ﻿      amendment   to credit agreement dated march   by and among kadmon pharmaceuticals llc the guarantors from time to time party thereto the lenders from time to time party thereto and perceptive credit holdings lp      press release of kadmon holdings inc dated april   ﻿ ﻿ ﻿   ﻿ ﻿ ﻿ signature pursuant to the requirements of the securities exchange act of  the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized   ﻿                           kadmon holdings inc       date april         s konstantin poukalov         konstantin poukalov         executive vice president chief financial officer ﻿     exhibit  ﻿ amendment  to credit agreement and amendment to warrant certificates ﻿ this amendment  to credit agreement and amendment to warrant certificates dated as of march   this “ third   amendment ” is made among kadmon pharmaceuticals llc    a   pennsylvania   limited   liability   company   the   “ borrower ” certain affiliates of the borrower listed on the signature pages hereof under the heading “guarantors” each a “ guarantor ” and collectively the “guarantors” and the lenders listed on the signature pages hereof under the heading “lenders” each a “ lender ” and collectively the “ lenders ” with respect to the credit agreement referred to below  recitals whereas the borrower the guarantors and the   lenders   are parties to a credit   agreement   dated   as of   august   as subsequently amended or otherwise modified including pursuant to this third amendment the   “ credit   agreement ” ﻿ whereas in connection with the making of the loans under the credit agreement the borrower executed and issued warrant certificates as defined in the credit agreement to the lenders which warrant certificates were originally issued on august   and in connection with the amendment and restatement thereof were reissued on december   ﻿ whereas   on the terms and subject to the conditions set forth herein the parties   hereto desire   to amend the existing credit   agreement defined below as set   forth   herein and ﻿ whereas on the terms and subject to the conditions set forth herein the parties also desire to amend the existing warrant certificates defined below as set forth herein ﻿ now   therefore in consideration of   the   mutual agreements   provisions   and   covenants   contained herein the parties hereto agree as   follows ﻿ section  definitions interpretation  a terms defined andor used in credit agreement      all capitalized terms used in this third amendment including   in the preamble and recitals hereof and   not otherwise defined herein shall have the   meanings   assigned to them in the credit agreement b terms defined in this third amendment   the following terms when used in this third amendment shall have the following meanings such meanings to be equally applicable to the singular and plural forms thereof   “ borrower ” is defined in the preamble  “ credit agreement ” is defined in the first recital  “ existing credit agreement ” means the credit agreement as in effect immediately prior to the third amendment effective date “ existing warrant certificate ” means any warrant certificate as in effect immediately prior to the third amendment effective date “ guarantor ” is defined in the preamble  “ third amendment ” is defined in the preamble  “ third amendment effective date ” is defined in section   c interpretation   the rules of interpretation set forth in section      and  of the credit   agreement shall be applicable to this third amendment   and are incorporated herein by   this reference section  amendments to existing credit agreement      e ffective as of and subject to the occurrence of the third amendment effective date the existing credit agreement is hereby amended as follows a section  of the existing credit agreement is hereby amended by adding the following defined terms in their alphabetically appropriate places “ excluded asset sale ” means any asset sale permitted pursuant to i clauses a through h of section  and ii to the extent but only to the extent x such asset sale is consummated during the period from the third amendment effective date to december   and y is permitted pursuant to the proviso to section bi    clause j of section   ﻿ “ third amendment ” means amendment  to the credit agreement dated as of march   made among the borrower the guarantors parties thereto and the lenders parties thereto ﻿ “ third amendment effective date ” means march   the date the parties hereto mutually agree that the third amendment became effective  ﻿ b section  of the existing credit agreement is hereby further amended by amending and restating in its entirety the definition of “ warrant certificate ” set forth therein to read as follows “ warrant certificate ” means each warrant certificate substantially in the form of exhibit i  executed and delivered by holdings in favor of a lender pursuant to section giv  as any such certificate may be subsequently amended replaced substituted or otherwise modified   c section a of the existing credit agreement is hereby amended in its entirety and to read as follows “ repayment   until the payment date occurring on january   no payments of principal of the loans shall be due  commencing with such payment date and on each payment date occurring thereafter the borrower shall repay the outstanding principal of the loans at par in an amount equal to  by paying to each lender its proportionate share of such amount on such payment date  to the extent not previously paid the outstanding principal amount of the loans together with all other outstanding obligations shall be due and payable on the maturity date” ﻿ d section bi of the existing credit agreement hereby amended in its entirety to read as follows “ asset sales  in the event of any contemplated asset sale or series of asset sales yielding net proceeds which when aggregated with the net proceeds of all other asset sales other than any excluded asset sale made after the date hereof exceed  borrower shall make a mandatory prepayment in respect of the loans as follows x if the assets sold represent substantially all of the assets or revenues of borrower or represent the sale of all or substantially all of the assets or revenues of any specific line of business which either on its own or together with other lines of business sold over the term of this agreement account for revenue generated by such lines of business exceeding  of the revenue of borrower in the immediately preceding year borrower shall make a mandatory prepayment of the loans in an amount equal to the redemption price for all loans applicable on the date of such asset sale y in the case of any asset sale permitted under section i  borrower shall make a mandatory prepayment of the loans in an amount equal to  of the net proceeds of such asset sale which amount shall be applied to the redemption price applicable on the date of such asset sale and z in the case of all other asset sales not described in the foregoing clauses x and y  borrower shall make a mandatory prepayment of the loans in an amount equal to the entire amount of the net proceeds of such asset sale which amount shall be applied to the redemption price applicable on the date of such asset sale credited in all cases described in clauses x y and z above in the order set forth in section bv e section j of the existing credit agreement is hereby amended in its entirety to read as follows “asset sales that x are not otherwise described in this section  and y are in respect of assets or properties that  if sold or otherwise disposed of during the period from the third amendment effective date to december   have a fair market value that does not exceed  in the aggregate for all properties and assets sold or otherwise disposed of during such period and  if sold or otherwise disposed of at any other time have a fair market value that does not exceed  in the aggregate for all assets or properties sold or   disposed of since the closing date exclusive of assets or properties sold or otherwise disposed of during the period described in clause y above” f section  of the existing credit agreement is hereby amended in its entirety to read as follows “future capital raising  during the period commencing with the third amendment effective date and ending on december    holdings shall have received an aggregate amount not less than  from a gross cash proceeds resulting from one or more sales offerings or issuances of its qualified equity interests b gross cash proceeds resulting from nondilutive funding from or arising out of one or more strategic transactions  eg licensing deal business development transaction etc entered into after the third amendment effective date but on or prior to december   and approved by the board of directors of holdings or c cash net proceeds from one or more asset sales permitted pursuant to section j ” ﻿ section  amendments to existing warrant certificates   e ffective as of and subject to the occurrence of the third amendment effective date each outstanding existing warrant certificate is hereby amended as follows  a section  of each existing warrant certificate is hereby amended by amending and restating the definitions of “ exercise price ” and “ rule  ” in their respective entireties to read as follows ﻿ “ exercise price ” means subject to adjustment pursuant to sections a and bi  a price per warrant share equal to  “ rule  ” means rule  under the securities act as amended b section     of each existing warrant certificate is hereby further amended by deleting the defined term “cashless exercise” ﻿ c section b of each existing warrant certificate is hereby amended and restated in its entirety to read as follows ﻿ “b        payment of the aggregate exercise price     when due and payable hereunder the holder shall pay the aggregate exercise price to the company by delivery of a certified or official bank check payable to the order of the company or by wire transfer of immediately available funds to an account designated in writing by the company” d section  of each existing warrant certificate is hereby amended by amending and restating the first paragraph of such section in its entirety to read as follow s ﻿ “upon the occurrence and during the continuance of any event of default at the option of the holder exercised by way of delivery of written notice to the company a “ redemption notice ” the holder shall have the right to terminate this warrant   certificate and demand a redemption of the warrant shares representing the then unexercised portion of this warrant certificate an “ early redemption ”” ﻿ section  conditions of effectiveness   this third amendment shall become effective upon and shall be subject to the prior or simultaneous satisfaction of each of the following conditions in a manner reasonably satisfactory to the lenders the date when all such conditions are so satisfied being the “ third amendment effective date ” a the lenders shall have received counterparts of this third amendment executed on behalf of the borrower guarantors and all lenders ﻿ b the representations warranties and reaffirmations set forth in section  below shall be true and correct ﻿ c the lenders shall have received all fees costs and expenses due and payable pursuant to section aiz of the credit agreement including without limitation the reasonable fees and expenses of morrison  foerster llp counsel to the lenders if then invoiced together with all other fees separately agreed to by the borrower and the lenders ﻿ d all legal matters incident to the effectiveness of this third amendment shall be reasonably satisfactory to the lenders ﻿ section  representations and warranties reaffirmation   a the obligors hereby jointly and severally represent and warrant to each lender as follows i each obligor has full power authority and legal right to make and perform this third amendment  this third amendment is within each obligor’s corporate powers and has been duly authorized by all necessary corporate and if required by all necessary shareholder action  this third amendment has been duly executed and delivered by each obligor and each of this third amendment and the credit agreement as amended hereby and each other loan document to which such obligor is a party constitutes a legal valid and binding obligation of such obligor enforceable against each obligor in accordance with its terms except as such enforceability may be limited by a bankruptcy insolvency reorganization moratorium or similar laws of general applicability affecting the enforcement of creditors’ rights and b the application of general principles of equity regardless of whether such enforceability is considered in a proceeding in equity or at law  neither this third amendment nor the credit agreement x requires any consent or approval of registration or any other action by any governmental authority or any third party except for such as have been obtained or made and are in full force and effect y violates any applicable law or the charter bylaws or other organizational documents of any obligor or any of its subsidiaries or any order of any governmental authority other than any such violations that individually or in the aggregate could not reasonably be expected to have a material adverse effect or z violates or would reasonably be expected to result in an event of default under any material agreement binding   upon such obligor or any of its subsidiaries or assets or give rise to a right thereunder to require any payment to be made by any such person ii the representations and warranties set forth in each loan document in each case are true and correct in all material respects with the same effect as if then made unless stated to relate solely to an earlier date in which case such representations and warranties shall be true and correct in all material respects as of such earlier date iii no default or event of default has occurred or is continuing or will result after giving effect to this third amendment  b each obligor hereby ratifies confirms reaffirms and acknowledges its obligations under each loan document including without limitation the credit agreement to which it is a party and agrees that each such loan document remains in full force and effect undiminished by this third amendment except as expressly provided herein provided that after the third amendment effective date all references in any loan document to the “credit agreement” “loan document” “thereunder” “thereof” or words of similar import shall mean the existing credit agreement and the loan documents as amended or otherwise modified by this third amendment  by executing this third amendment each obligor acknowledges that it has read consulted with its attorneys regarding and understands this third amendment section  guarantors’ acknowledgement and consent   each guarantor has read this third amendment and consents to the terms hereof and hereby acknowledges and agrees that any loan document to which such person is a party shall continue in full force and effect and that all of its obligations thereunder shall be valid binding and enforceable except as enforceability may be limited by bankruptcy insolvency reorganization moratorium or similar laws relating to or limiting creditors’ rights generally and by equitable principles relating to enforceability and shall not be impaired or limited by the execution or effectiveness of this third amendment  each guarantor acknowledges and agrees that i such person is not required by the terms of the credit agreement or any other loan document to consent to the supplements and amendments to the credit agreement effected pursuant to this third amendment and ii nothing in the credit agreement this third amendment or any other loan document shall be deemed to require the consent of such person to any future supplements or amendments to the credit agreement section  miscellaneous  a no waiver   nothing contained herein shall be deemed to constitute a waiver of compliance with any term or condition contained in the existing credit agreement the credit agreement or any of the other loan documents or constitute a course of conduct or dealing among the parties  except as expressly stated herein the lenders reserve all rights privileges and remedies under the loan documents  except as expressly amended hereby the credit agreement and other loan documents remain unmodified and in full force and effect b severability   in case any provision of or obligation under this third amendment shall be invalid illegal or unenforceable in any jurisdiction the validity legality and   enforceability of the remaining provisions or obligations or of such provision or obligation in any other jurisdiction shall not in any way be affected or impaired thereby c headings   headings and captions used in this third amendment including the exhibits schedules and annexes hereto if any are included for convenience of reference only and shall not be given any substantive effect d integration   this third amendment constitutes a loan document and together with the other loan documents incorporates all negotiations of the parties hereto with respect to the subject matter hereof and is the final expression and agreement of the parties hereto with respect to the subject matter hereof  this third amendment shall unless otherwise expressly indicated therein be construed administered and applied in accordance with all of the terms and provisions of the credit agreement including section  thereof including without limitation sections      and   e this third amendment shall be binding upon and inure to the benefit of the parties hereto and their respective successors and permitted assigns f counterparts   this third amendment may be executed in any number of counterparts all of which taken together shall constitute one and the same instrument and any of the parties hereto may execute this third amendment by signing any such counterpart g controlling provisions   in the event of any inconsistencies between the provisions of this third amendment and the provisions of any other loan document the provisions of this third amendment shall govern and prevail  except as expressly modified by this third amendment the loan documents shall not be modified and shall remain in full force and effect in witness whereof the parties hereto have duly executed this third amendment as of the date first above written borrower ﻿ ﻿ kadmon pharmaceuticals llc ﻿ by  harlan w waksal president and chief executive officer ﻿ ﻿ guarantors ﻿ ﻿ kadmon corporation llc ﻿ by    harlan w waksal president and chief executive officer ﻿ ﻿ kadmon holdings inc fka kadmon holdings llc ﻿ by  harlan w waksal president and chief executive officer ﻿ ﻿ kadmon research institute llc ﻿ by  harlan w waksal president and chief executive officer ﻿ ﻿ three rivers research institute i llc ﻿ by  harlan w waksal president and chief executive officer   three rivers biologics llc ﻿ by  harlan w waksal president and chief executive officer ﻿ ﻿ three rivers global pharma llc ﻿ by  harlan w waksal president and chief executive officer ﻿   collateral representative ﻿ ﻿ perceptive credit holdings lp by perceptive credit opportunities gp llc its general partner ﻿ by  sandeep dixit chief credit officer ﻿ by  name title ﻿   lenders ﻿ ﻿ perceptive credit holdings lp by perceptive credit opportunities gp llc its general partner ﻿ by  sandeep dixit chief credit officer ﻿ by  name title ﻿   goldentree credit opportunities lp by goldentree asset management lp ﻿ by  name title ﻿ goldentree credit opportunities ltd by goldentree asset management lp ﻿ by  name title ﻿ goldentree insurance fund series interests of the sali multiseries fund lpby goldentree asset management lp by goldentree asset management lp ﻿ by  name title ﻿ gt nm lp by goldentree asset management lp ﻿ by  name title ﻿ san bernardino county employees’ retirement association by goldentree asset management lp ﻿ by  name title ﻿ ﻿ ﻿     exhibit  ﻿ ﻿ kadmon announces amendment to credit agreement and related warrants new york april   — kadmon holdings inc nyse kdmn “kadmon” or the “company” today announced that the company together with its lending syndicate led by perceptive credit opportunities fund entered into an amendment to its  credit agreement and related warrants  terms of the amendment include but are not limited to · deferring the capital raise requirement of  million from june   to december    additionally proceeds from nondilutive funding sources such as business development transactions may be counted toward this capital raise · deferring mandatory monthly principal payments until january   and · amending  previously issued warrants to cash warrants and adjusting the warrant strike price to   “we are pleased to work with our lenders led by perceptive credit opportunities fund to enter into this amendment which enables us to continue to focus our resources toward advancing our pipeline of promising clinical and preclinical product candidates” said harlan w waksal md president and ceo at kadmon    about kadmon holdings inc kadmon holdings inc is a fully integrated biopharmaceutical company developing innovative products for significant unmet medical needs we have a diversified product pipeline in autoimmune and fibrotic diseases oncology and genetic diseases forwardlooking statements this press release contains forwardlooking statements such statements may be preceded by the words “may” “will” “should” “expects” “plans” “anticipates” “could” “intends” “targets” “projects” “contemplates” “believes” “estimates” “predicts” “potential” or “continue” or the negative of these terms or other similar expressions forwardlooking statements involve known and unknown risks uncertainties and other important factors that may cause our actual results performance or achievements to be materially different from any future results performance or achievements expressed or implied by the forwardlooking statements we believe that these factors include but are not limited to i the initiation timing progress and results of our preclinical studies and clinical trials and our research and development programs ii our ability to advance product candidates into and successfully complete clinical trials iii our reliance on the success of our product candidates iv the timing or likelihood of regulatory filings and approvals v our ability to expand our sales and marketing capabilities vi the commercialization of our product candidates if approved vii  the pricing and   reimbursement of our product candidates if approved viii the implementation of our business model strategic plans for our business product candidates and technology ix the scope of protection we are able to establish and maintain for intellectual property rights covering our product candidates and technology x our ability to operate our business without infringing the intellectual property rights and proprietary technology of third parties xi costs associated with defending intellectual property infringement product liability and other claims xii regulatory developments in the united states europe and other jurisdictions xiii estimates of our expenses future revenues capital requirements and our needs for additional financing xiv the potential benefits of strategic collaboration agreements and our ability to enter into strategic arrangements xv our ability to maintain and establish collaborations or obtain additional grant funding xvi the rate and degree of market acceptance of our product candidates xvii developments relating to our competitors and our industry including competing therapies xviii our ability to effectively manage our anticipated growth xix our ability to attract and retain qualified employees and key personnel xx our ability to achieve cost savings and other benefits from our efforts to streamline our operations and to not harm our business with such efforts and xxi the use of proceeds from our recent private placement more detailed information about kadmon and the risk factors that may affect the realization of forwardlooking statements is set forth in the companys filings with the us securities and exchange commission sec including the companys annual report on form k filed pursuant to section  of the securities exchange act of  as amended with the sec on march   investors and security holders are urged to read these documents free of charge on the secs web site at wwwsecgov the company assumes no obligation to publicly update or revise its forwardlooking statements as a result of new information future events or otherwise ﻿ contact information ellen tremaine investor relations  ellentremainekadmoncom maeve conneighton  maeveargotpartnerscom   ﻿ united states securities and exchange commission washington dc      form k     current report pursuant to section  or d of the securities exchange act of  date of report date of earliest event reported april    march      kadmon holdings inc exact name of registrant as specified in its charter       ﻿                   delaware       state or other jurisdiction of incorporation   commission file number   irs employer identification no      east  th street new  york ny    address of principal executive offices   zip code registrant’s telephone number including area code   na former name or former address if changed since last report     check the appropriate box below if the form k filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions   ☐ written communications pursuant to rule  under the securities act  cfr    ☐ soliciting material pursuant to rule a under the exchange act  cfr a   ☐ precommencement communications pursuant to rule db under the exchange act  cfr db   ﻿   ☐ precommencement communications pursuant to rule ec under the exchange act  cfr ec   ﻿     item  other events on march   kadmon holdings inc the “company” submitted an abbreviated new drug application to the us food and drug administration fda   for kd   the company’s trientine hydrochloride formulation   this is the second application submitted to the fda by any company for a generic trientine hydrochloride product for the treatment of wilson’s disease in patients who are intolerant of penicillamine  wilson’s disease is a genetic liver disease characterized by an inability to excrete copper causing severe hepatic neurologic psychiatric and ophthalmic abnormalities the full text of the press release is attached to this current report on form k as exhibit  ﻿ ﻿   item  financial statements and exhibits d exhibits   ﻿   exhibit no description ﻿    press release dated april    issued by kadmon holdings inc ﻿ ﻿ ﻿ ﻿   ﻿ signature pursuant to the requirements of the securities exchange act of  the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized   ﻿                           kadmon holdings inc       date april          s konstantin poukalov         konstantin poukalov         executive vice president chief financial officer     exhibit  ﻿ ﻿ kadmon submits second abbreviated new drug application filing for trientine hydrochloride to fda  product to offer room temperature storage representing unique advantage over currently marketed formulations   new york april   – kadmon holdings inc nyse kdmn “kadmon” or the “company” today announced that on march   it submitted its second abbreviated new drug application anda to the us food and drug administration fda for kd the company’s trientine hydrochloride formulation for the treatment of wilson’s disease a rare genetic liver disorder for patients who are intolerant of penicillamine  the company also submitted an anda for a bottled form of trientine hydrochloride in december    this second anda is for kadmon’s generic version of trientine hydrochloride in blister packaging that offers room temperature storage which the company believes has the potential to address shortcomings of currently available trientine hydrochloride formulations  “we are pleased to submit our second anda for our trientine hydrochloride formulation offering room temperature storage which if approved we believe will enhance patient convenience and optimize disease management” said harlan w waksal md president and ceo at kadmon  “we remain committed to improving the lives of patients living with wilson’s disease and look forward to providing updates on the fda review process” about kadmon holdings inc kadmon holdings inc is a fully integrated biopharmaceutical company focused on developing innovative products for significant unmet medical needs  we have a diversified product pipeline in oncology autoimmune and fibrotic diseases and genetic diseases   safe harbor statement this press release contains forwardlooking statements such statements may be preceded by the words “may” “will” “should” “expects” “plans” “anticipates” “could” “intends” “targets” “projects” “contemplates” “believes” “estimates” “predicts” “potential” or “continue” or the negative of these terms or other similar expressions forwardlooking statements involve known and unknown risks uncertainties and other important factors that may cause our actual results performance or achievements to be materially different from any future results performance or achievements expressed or implied by the forwardlooking statements we believe that these factors include but are not limited to i the initiation timing progress and results of our preclinical studies and clinical trials and our research and development programs ii our ability to advance product candidates into and successfully complete clinical trials iii our reliance on the success of our product candidates iv the   timing or likelihood of regulatory filings and approvals v our ability to expand our sales and marketing capabilities vi the commercialization of our product candidates if approved vii  the pricing and reimbursement of our product candidates if approved viii the implementation of our business model strategic plans for our business product candidates and technology ix the scope of protection we are able to establish and maintain for intellectual property rights covering our product candidates and technology x our ability to operate our business without infringing the intellectual property rights and proprietary technology of third parties xi costs associated with defending intellectual property infringement product liability and other claims xii regulatory developments in the united states europe and other jurisdictions xiii estimates of our expenses future revenues capital requirements and our needs for additional financing xiv the potential benefits of strategic collaboration agreements and our ability to enter into strategic arrangements xv our ability to maintain and establish collaborations or obtain additional grant funding xvi the rate and degree of market acceptance of our product candidates xvii developments relating to our competitors and our industry including competing therapies xviii our ability to effectively manage our anticipated growth xix our ability to attract and retain qualified employees and key personnel xx our ability to achieve cost savings and other benefits from our efforts to streamline our operations and to not harm our business with such efforts and xxi the use of proceeds from our recent private placement more detailed information about kadmon and the risk factors that may affect the realization of forwardlooking statements is set forth in the companys filings with the us securities and exchange commission sec including the companys annual report on form k filed pursuant to section  of the securities exchange act of  as amended with the sec on march   investors and security holders are urged to read these documents free of charge on the secs web site at wwwsecgov the company assumes no obligation to publicly update or revise its forwardlooking statements as a result of new information future events or otherwise contact information ﻿ ellen tremaine investor relations  ﻿ ellentremainekadmoncom ﻿ maeve conneighton  ﻿ maeveargotpartnerscom ﻿ microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft barrons market lab table  barronscom wsj wsj wsj live wsj live marketwatch marketwatch barrons barrons facebook twitter product x product x djx rt f rc pevc wsj b more bigcharts financial news professor journal smartmoney student journal virtual stock exchange wsj classifieds wsj classroom wsj radio wsj wine search headline goldman companies gold ran gold resources ltd ads us view all search results » subscribe log in welcome customer center logout live help home magazine this weeks edition past editions daily all coverage barrons take weekday trader up  down wall st daily getting technical striking price daily wall streets best minds read this spike that stocks to watch today income investing tech trader daily focus on funds emerging markets inside scoop qa investing ideas overview barrons picks  pans mutual funds  etfs hedge funds stocks center commodities center bonds center options center barrons take weekday trader stock alert inside scoop ahead of the crowd focus on funds stocks to watch today barrons roundtable advisor center market data market data center market lab economic calendar stock grader stock  fund tables barrons  penta penta magazine penta daily penta archives barrons next monday february   hedge fund performance this table gives performance data for hedge funds that have reported assets for the month to the morningstar hedge fund database the returns are net of fees the funds are listed alphabetically the morningstar hedge fund database is the sole source of hedge fund and cta data for barronsalternativeinvestmentsmorningstarcom for inclusion in the morningstar database and for further information please email hedgefundsmorningstarcom  or call   funds of funds  commodity trading advisors typefundjune  returnytd  returnmonth  return year  return year  returnmonth  annualized standard deviationmonth  maximum drawdownassets   million capital structure arbitrage argent classic convert arbitr fund ii lp c piedmont alpha  fundnana piedmont alpha  fundnana piedmont alpha  fundnana convertible arbitrage casam cisdm convertible arbitrage indexna acuity fund ltd acuity partners lp advent convertible arbitrage cayman feeder argent classic convert arbitr fund ii lp a argent classic convert arbitr fund ii lp b argent classic convertible arbitrage fund a argent classic convertible arbitrage fund b argent classic convertible arbitrage fund c argent classic convertible arbitrage lp a argent classic convertible arbitrage lp b argent classic convertible arbitrage lp c argent lowlev convert arbitr fund ii llc ana argent lowlev convert arbitr fund ii llc b argent lowlev convert arbitr fund ii llc c argent lowlev convertible arbitrage ltd a argent lowlev convertible arbitrage ltd b argent lowlev convertible arbitrage ltd c castle creek arbitrage llcna concordia capital class b volatility arb inflective convertible arbitrage composite inflective convertible opportunity fund i inflective convertible opportunity fund ina jb convertible bond hedge fund eur na jb convertible bond hedge fund eur nanananana jb convertible bond hedge fund usd na jb convertible bond hedge fund llcnana rock hill international partners ltd rock hill investment partners lp ssi hedged convert makret neutral unlevered ssi hedged convertible income fund lpnanananana ssi hedged convertible opportunity fund lp steelhead pathfinder fund lpnana steelhead pathfinder fund ltdnana wafra starvest convertible securities ltd zazove convertible arbitrage fund lp zazove hedged convertible fund lp zazove income fund lp distressed securities casam cisdm distressed securities indexna ahab distressed lpnanananana ahab opportunities lp ahab opportunities ltd alcentra european credit fund eurna alcentra european credit fund usdna american durham armory fund lpna armory offshore fund ltdna bay harbour  ltd bay harbour credit opportunities ltdna bay harbour credit opportunities llcna bay harbour partners ltd brownstone partners catalyst fund offshorena brownstone partners catalyst fund onshorena concordia distressed debt fund class h dkr wolf point fund ltdna international durham ltd md sass reenterprise ii lp md sass reenterprise international ltd md sass reenterprise partners lp manley investment partners lp md sass reenterprise international ltd md sass reenterprise partners lp outrider offshorena outrider onshorena penn distressed fund lp post distressed fund lp post distressedoffshore fund ltd restoration offshore fund ltd restoration partners llcnana trophy hunter investments ltd trophy hunter partners ltd wexford credit opportunities fund lp wexford offshore credit opp fund limited wilfrid aubrey growth fund wilfrid aubrey international zazove high yield convert securities fund lp emerging markets casam cisdm emerging markets indexna access turkey opportunities fund llc alphagen pictor fund class a usd alphagen pictor fund class b eurnana alphagen pictor fund class c jpynana alpinex ls gl emerg mark fixed inc fundnana alpinex ls global emerg markets equity fundnana asia focus fund lpnanananana avatar india opportunities fundnana axiom absolute growth fund baring emea absolute return fund usdnana blackrock middle east  north africa fundnanananana bm greater china asia fund ii ltdna bm greater china asia fund lpna boyer allan india fundna challenger charlemagne capital russia fund class a charlemagne capital russia fund ord class charlemagne magna russia fund class a charlemagne magna russia fund class c compass income fund d constans crescent investment fund oeicnana copernico argentina fund copernico latin america strategic class a denholm hall russia arbitrage fund  e sharesnanananana dexia long short emerging market fundna dexia money  emerging arbitragenana dolphin fund plc dynamic power emerging markets fundnana eight capital master fundnana emerging income fundna emerging value opport fund  series b fama brazil fund  equity market neutralna fama brazil fund  equity value classna fama brazil fund  valor classnana fh emerging markets debt fund ltd fh emerging markets debt fund lp finisterre global opportunities fundnana finisterre sovereign debt fund finisterre special situations fundnana firebird avrora fund ltdna firebird fund lp firebird global fund ii lpnana firebird global fund ii ltdnana firebird new russia fund ltd firebird republics fund ltd forum absolute return fund ltd forum asset based invesment fundnanananana forum global opportunities fund ltdnana forum hard assets fund ltdnana foyil east europe russia focus fund institnana foyil eastern europe and russia focused fund fpp golden asia fundnana futurewatch i gfm levant fundnana globalis sovereign growth and income fund lp globalis sovereign growth and income fund ltd gramercy emerging markets fund llc gramercy emerging markets fund ltd greater asian hedge fund green cay emerging markets fundnana greylock global opportunity fund lp greylock global opportunity fund ltd harmonic global fund currency class horizon growth fund nv hudson river russia fund ltdnana jb emerging markets hedge fund chfna jb emerging markets hedge fund eurna jb emerging markets hedge fund usdna lazard emerging income lpna lazard emerging income ltd class ana lazard emerging income plus ltdnana lg asian plus limited mars emerging markets equity pcnana mars emerging markets fund memfna martin currie arf  asia fund usd martin currie arf  china hedge fund euro martin currie arf  china hedge fund usd maua brasil equities fundnana maua brasil fundna maua brasil plus fundnana mercury international fund equitiesna mercury international fund hedged equities metage emerging market opportunities fund mpm pan china fundnanananana mpm pure china fundna occo eastern european fund occo global emerging markets fund class a usdna occo global emerging markets fund class b eurna optima emerging markets fund limitedna optima opportunity fund pamplona global emerging markets fund class anana pharos gas investment fundna pharos russia fund pharos small cap fundnana polunin capital partn devel countries fund polunin emerging markets active fund prosperity cub fund prosperity quest fund qbridge china fundnana quest select fund rab emerging markets opportunities fund  anana rab emerging markets opportunities fund  bnana rab emerging markets opportunities fund  cnana rab emerging markets opportunities fund  dnana rab emerging markets opportunities fund  pnana rab emerging markets opportunities fund  qnana red cobra fundna russian opportunities fund ltd russian prosperity fund a russian prosperity fund b russian prosperity fund cna russian prosperity fund j sc asian opportunity fund lpnana senvest israel partners smc china opportunity fund i class anana smc china opportunity fund i class bnana sniper spectrum cis value fundnana spectrum russia absolute return fund striker na tarpon all equities fundnana tarpon fund thames river high income fund euro accna thames river high income fund euro thames river high income fund gbp thames river high income fund new eurona thames river high income fund new gbpna thames river high income fund new nokna thames river high income fund new usdna thames river high income fund nokna the tantallon bric non us feeder fundnana tm indiastar fundna tradewinds fund cayman ltdnana tradewinds fund lp tradewinds russia partners i lp tradewinds russia value fund llc troika russia fund us  monthlynana troika russia fund us monthlynana troika russia fund eur  monthlynana troika russia fund eur monthlynana turkey opportunity fundna ubs pactual equities fund ubs pactual strategy fund ubs pactual symmetry fund wessex asia pacific fund  class anana wessex asia pacific fund  class b worldwide opportunity fund cayman ltd class cna equity long only aquamarine fund inc arab gateway fund ltd arab islamic gateway fund ltdnana arx brazil fund spc  long only classnana bulwark capital partners lpnana cal global growth fund cambrian fund ltd class a capital moving  storage lpnana connective capital emerging energy qp lpnanananana custodia asian fundnana custodia european equity fundnana custodia north american equity fundnana cutler investment fund lp emirates gateway fund ltd globersel bcm convertible bondnana gutzwiller one hanseatic large cap kr capital partners fund i lp kuwait gateway fund ltdnana longterm investment fund sia classic chf longterm investment fund sia classic eur longterm investment fund sia classic usd longterm investment fund sia stability chfnana martin currie arf global financials fund eurnana moneda deuda latinoamericana moneda latin american debt fundnanananana nakoma equity fund lp oman gateway fund ltdna orbis japan equity fund limited euro orbis japan equity fund limited us orbis japan equity fund limited yen pabrai investment fund  protostar master fund ltdnana saudi gateway fund ltdnana scopia long llcna select contrarian value partners lp sokol russian equity opport offshore fundnana thames river european fund class a eur thames river european fund class b gbp thames river japan fund eur thames river japan fund gbp the tantallon bass rock nonus feeder fundnanananana third avenue value equity offshore fund ltdnana equity longshort casam cisdm equity longshort indexna  partners lp absolute value fund lllp act ii partners lp adhia derivative fund lp adi long short europe ana advisory research microcap value fund lp ais capital growth fund lp ajr international class a akamatsu fund class a jpyna akamatsu fund class b usdna alerian capital internationalnana alerian capital partnersna alpha equity intern market neutral fundna alpha equity international  fund lp alphagen acamar fund class a usdnana alphagen acamar fund class b euronana alphagen acamar fund class c gbpnana alphagen aldebaran eur class bna alphagen aldebaran eur class bna alphagen aldebaran gbp class dna alphagen aldebaran gbp class dnana alphagen aldebaran jpy class cna alphagen aldebaran jpy class cnanananana alphagen aldebaran usd class ana alphagen aldebaran usd class ana alphagen aldebaran usd class enanananana alphagen avior class b euro alphagen avior fund class a usd alphagen avior fund class c gbp alphagen capella fund limited class a usd alphagen capella fund limited class b eur alphagen dorados fund class a usdnana alphagen dorados fund class d usdnana alphagen hokuto fund class a usd alphagen hokuto fund class b jpy alphagen pyxis fund jpyna alphagen pyxis fund usdna alphastream us large cap  equitynana amphora fund lllp aquamarine value fund lp arcus japan longshort fund yen arcus zenkei fund class a usdna arcus zenkei fund class b jpyna arcus zenkei fund class c eurona arcus zensen fund class a usd arcus zensen fund class b jpy argentum multistrategy fund ltdna argonaut global equities partnership lp aria partners lp aria select consumer fund lp armor capital partners lp armor qualified lpnana arx brazil fund spc long short enhanced classnanananana arx brazil fund spc  long short classnana ascend partners fund  lp ascend partners fund i ltd ascend partners fund ii lpna ascend partners fund ii ltdna ascend quantitative longshort lpnana ascend quantitative longshort ltdnana aslan capital fund i qp lp asterx europe fund asterx panorama fundnana auda equity longshort ltd baker street capital partners lp baring china absolute return fund usdna bay ii resource partners lp bay resource partners lp bay resource partners offshore fund ltd bdi partners lpnana binjai hill asian acorns fundna birckennbach investmentsnana blue sky japan lp blumont canadian opportunities fund blumont hirsch longshort blumont hirsch performance fund bomgaars investments fundnana boyer allan greater china fundnana boyer allan japan fund class a usd boyer allan japan fund class b yen boyer allan pacific fund inc non new issue boyer allan pacific opportunities fundnana broadfin healthcare fund lp class anana broadfin healthcare fund lp class bnana broadfin healthcare offshore fund ltdnana broadmark longshort full exposure lpna broadmark value hedged lpnana broadmark value hedged offshore ltdnana bryan garnier european growth long short fundnana btr global energy fundnana btr global opportunity fund btr global prospector fund btr global resource fundna c  o investment partnership lp cal global hedge fundna capital standard longshort fund lp catalyst associates lp ccm small cap value fund cedar street fund lp cedar street offshore fund cerulean partners ltd chess river uk equity fundna chinafund cayman ltd clay capital fund lpnana connective capital i lpna copernico latin america strategic class bna copernico latin america strategic class cna crest equity partners lp crm windridge partners ii lpna crm windridge partners lp crm windridge partners ltdna crosslink partners lp crow point utility and telecommunication fundnana crown investment partners lp dalton asia fundnanananana dalton greater china fundna dalton pacific and general investments defiance fund ltd dexia longshort double alpha euro dghm enhanced value lp diamond hill investment partners ii lpnana diamond hill investment partners lp diamond hill offshore fund ltdnana difiglia partners lpna dividend plus capital partners lpna dkr neutrino programnana dunlap capital partners dynamic alpha performance fund  a dynamic income opportunities fund  anana dynamic power hedge fund dynamis partners fund lpnanananana eagle aggressive growth partners lp i eagle capital partners fund eagle capital partners lp eastern advisors llc ecofin global utilities hedge fund lpnana ecofin north american utilities hedge fundnanananana ecofin north american utilities hedge fund lpnanananana ecofin north american utilities hedge fund nnanananana ecofin special situations utilities fund anana ecofin special situations utilities fund cnana ecofin special situations utilities fund dnana ecofin special situations utilities fund lp anana ecofin special situations utilities fund lp bnana ecofin special situations utilities fund lp cnana ecofin special situations utilities fund lp dnana ecofin special situations utilities ltd cls bnana ek asia fund ek hong kong  china fund elkhorn fund elkhorn fund ltd elm ridge capital partners lp elm ridge offshore master fund ltd elm ridge value partners lp emerald bay partners lp emeralt emerging europe fundnanananana empirical capital partners lp ennismore european smaller comp hedge fund ennismore european smaller companies fund eur ennismore european smaller companies fund gbp entrust capital partners ii lp class ana entrust capital partners ii lp class bna entrust capital partners lp class a entrust capital partners lp class b entrust capital waters fund ltd class a entrust capital waters fund ltd class b eurasian capital partners fund euronova smaller companies fundnana exane prometheus fundna exane micromegas fundnana exane vauban fundna f  c zircon fundnanananana fairholme partners lp fairholme ventures ii llc ferrell asia fund financial investments lp firebird global fund ltd firebird global fund lp first state glob energy long short fund nana first state global energy long short fund nana first state global energy long short fund nana first state global energy long short fund anana five corners partners lp focused opportunities fundna fortis hedge cayman ls japan limitednana frontaura global frontier fund llcnanananana futuris fund gabelli japanese value partners lp gargoyle hedged value qp fund lp ggcp sequoia international ltdnana ggcp sequoia partners lpnana ginger capital fundna glenrock global partners bvi inc global fusion partners lpnana globalagricap fund  class ananananana globalagricap fund  class bnanananana globalmicrocap  class anana globalmicrocap  class bnana globersel bcm stock picker fundnana globis capital partners lp globis overseas fund ltdna goodwood capital fund goodwood fund class a goodwood fund class b granada europe fundnana granite point capital lpna greater china alpha advantage fundnanananana green dragon fundnana grenadier fund haberman value fund haidar jupiter fund llc hanover strategic value fund lpna harvest opportunity partners ii strategynana headstream value partners lp health sciences hedge fundnana hedgenergyna henderson asia pacific abs ret fund ltd henderson eur style rotational long short usdnana henderson eur st rotat long short fund gbpnana henderson european abs ret fund ltd eur henderson european abs ret fund ltd usd henderson european style rota long short eurnana henderson japan absolute return fund ltd jpy henderson japan absolute return fund ltd usd henderson uk equity long short fund ltd eur henderson uk equity long short fund ltd gbpnana henderson uk equity long short fund ltd usd highline capital international ltd class a highline capital partners qp lp highline capital partners lp hollis capital partners lp hornet infrastructure  water fund inanananana hornet opportunity ls equity fundna hsbc european alpha fund eur hsbc global technology alpha fund eurnana hsbc global technology alpha fund gbpnana hsbc global technology alpha fund usdnana ht asian alpha amoeba fund llcna ht asian catalyst fund llc hyerdale capitalnana ibis capital lp icmc global core value fund lp icmc tactical return fund ltd ikos equity hedge fund eur class imagine investment partners lpna indusino offshore fund ltdnana indusino partners llcnana insight fund lp intrinsic edge partners lp intrinsic edge plus lpnana ion partners alpha lpna iridian opportunity fund lpna iridian opportunity offshore fund ltdna jmbo fund jupiter asia pacif hdg fund gbp nonrestricnana jupiter asia pacif hdg fund usd nonrestricnana jupiter asia pacific hedge fund eur nonrestnana jupiter europa hedge fund euro class jupiter europa hedge fund limited usd class jupiter ganymede hedge fund euro classna jupiter ganymede hedge fund gbp classna jupiter ganymede hedge fund usd classna jupiter hyde park hedge fund usd class kinetics fund inc kingdon associates krohne fund lpna kts olympus partners kuromatsu fund class a jpynana kuromatsu fund class b usdnana la jolla partners lp lafitte fund ina lafitte fund i qpna lafitte fund i offshore ltdnana lake street fund lp lakefront partners lpna lampost blue chip fund lp lazard european discovery lpnana lazard european explorer ltdna lazard european explorer lpna lazard global opportunities lp lazard global opportunities ltd libra fund lp libra offshore ltd lindsell train global media fund lindsell train japan fund little wing lp longterm investment fund sia alpha chfna longterm investment fund sia alpha eurna longterm investment fund sia alpha usdna longview opportunities fund class a longview opportunities fund class cnana loyola capital fund ltd loyola capital partners lp loys global mhnana m kingdon offshore ltd mainstream active value fund ii lp mainstream active value fund lp mainstream active value offshorenana mainstream bonaparte mainstream global active value fund lpnana manalapan oracle eagle fund lp marathon partners lp marketus value partners lp martin currie arf  asia fund eurona martin currie arf  european fund euronana martin currie arf  european fund gbp martin currie arf  european fund usdnana martin currie arf  global energy fund eurnana martin currie arf  global energy fund usdnana martin currie arf  japan fund eurona martin currie arf  japan fund jpynana martin currie arf  japan fund usd martin currie arf  uk fund gbpna martin currie arf  uk fund usdnana martin currie arf global financials fund usdnana marwyn neptune fund lpnana mcginnis capital lpna md sass maximus partners lp mdm fundna melchior european fund eurnana melchior european fund gbpnana melchior european fund usdnana melchior global macro fund gbp melchior global macro fund usd melchior japan fund  gbpnana melchior japan fund  jpynana melchior japan fund  usdnana melchior japan fund eur melchior japan fund gbp melchior japan fund jpy melchior japan fund usd microcapital fund lp microcapital fund ltdna mirabaud euro actions eurna mirabaud france actions eurna mirabaud fund swiss small and mid caps chfna miruk hedge fund gbpna modern capital fund llcna modern capital fund ltdnana modern capital institutional fund llcnanananana mpc pilgrim fund class a eur mpc pilgrim fund class b usd mpc pilgrim fund class c gbp mq asia long short fundnana mtb investment partners lp nakoma partners lp navesink partners l p nes offshore ltd nes partners llc new millennium fundamental hedged equity lp new star european eur new star financials usd new star uk gemini gbpna nile master fund limitedna nokomis capital partners lpnanananana north  webster value opportunities fund lpnana northern rivers innovation fund lp northglen aggressive spcnana ocean partners llc odey capital strategies eurnana odey capital strategies gbpnana odey capital strategies usdnana odey european inc usd odey european inc euro odey european inc gbp ana odey european inc gbp bnanananana olesen capital lpnanananana orbis africa equity rand fund orbis asia exjapan equity fundnana orbis global equity fund orbis leveraged fund euro orbis leveraged fund us orbis leveraged fund yennana orbis optimal fund euro orbis optimal fund us orbis optimal fund yennana osmium capital lp otter creek international ltd otter creek partners i lp palmyra capital fund lp palmyra capital institutional fund lpna palmyra capital offshore fund ltd peconic partners international fund ltd pegasus fund gbp pegasus leveraged fund gbpna pemigewasset partners penn capital structure opportunities fund lp penn micro cap fund lpna permal europe eur persistix capital partners lpnanananana pike place capital offshore ltdna pike place partners ii lp pike place partners lp platinum fund platinum japan fund pmc global equity hedge fund inc class a pmc global equity hedge fund inc class i polar capital columbus fund ltd euronana polar capital columbus fund ltd gbpnana polar capital columbus fund ltd usdnana polar capital european conviction ltd eurnana polar capital european conviction ltd gbpnana polar capital european conviction ltd usdnana polar capital forager fund eurona polar capital forager fund ltd gbpna polar capital forager fund ltd usdna polar capital japan abs return fund jpy polar capital japan absolute return fund usd polar capital latin america fund ltd usdnana polar capital paragon abs ret fund gbpna polar capital paragon abs ret fund eurona polar capital paragon absolute return usdna polestar fund lpnana preservation capital preservation capital fund lpna preservation trust cad punch micro cap partners llcna qam asian equities fund ltdna qam global equities fund ltdna qmhf investments lpnana quantitative tactical fund llcnanananana quantitative tactical fund llc xnanananana quest capital partners lp rab emea fund class a eurna rab emea fund class b usdna rab emea fund class c eurna rab emea fund class d usdna rab emea fund class p gbpna rab emea fund class q gbpna rab europe fund class a eur rab europe fund class b usd rab europe fund class c eur rab europe fund class d usdnana rab europe fund class p gbpnana rab european credit opportunities a eur rab european dynamic fund class a gbpna rab european dynamic fund class b gbpna rab special situations fund class a usdna rab special situations fund class b eurna rab special situations fund class b gbpna rab uk fund class a eur rab uk fund class b usd rab uk fund class c eur rab uk fund class d usd rab uk fund class p gbp rab uk fund class q gbp railsplitter fund lp reachcapital international fund i ltd reachcapital international fund ii lp red star double alpha sp fundna reichmuth alpinna reichmuth bottom fishing reichmuth pilatus reichmuth voralpinnana resolution cartesian uk equity ls fund eurnana resolution cartesian uk equity ls fund usdnana resolution cartesian uk equity long short gbpnana resolution glob resour abs return fund eurnana resolution glob resour abs return fund gbpnana resolution glob resour abs return fund usdnana resolution hexam emea abs return fund eurnana resolution hexam emea abs return fund gbpnana resolution hexam emea abs return fund usdnana reyl absolute return fundna riverside global value fund riverside world wisdom fund rivoli equity fund eurona rivoli equity fund usdna roanoke partners lp robbins opportunity offshore fund ltd robbins opportunity partners lp rodinia fund ltdna sabre value fund lp sage opportunities fund offshore sage opportunities fund lp salus  enhanced equity strategyna sandler associates arnana sandler associates au sandler associates brnana sandler associates bunana sandler offshore fund sandler plus domestic fund onshorenana sandler plus fund offshorenana sc fundamental value bvi ltd sc fundamental value fund lp sc opportunity fund lpnana schafer cullen global small cap value lp scivest commodity index plus fundnana scivest net short equity fundna scopia international limited scopia partners llc scopia partners qp llcna scopia px internationalnana scopia px llc senvest partners sevenoaks offshore opportunities fundnanananana sevenoaks opportunities fund us series ananananana sevenoaks opportunities fund lp bnanananana sextant strategic global water fund class anana sextant strategic hybridhedge resor fund anana shaker investments tower fund lp shk asia dynamic fund ltdnana siebels hard asset fundna sierra europe lp sierra europe offshore ltd euro class class b sierra europe offshore ltd  usd class a silver capital fund offshore ltdna silver capital fund llc sio partners lpnana sm investors ii lp sm investors offshore ltd sm investors lp snow capital investment partners lp sofaer capital asian hedge fund sofaer capital european hedge fund eur sofaer capital european hedge fund usd sofaer capital global hedge fund sofaer capital japan hedge fund sofaer capital natural resources hedge fundnana sofaer capital pacific hedge fund somerset capital partners lp sprott capital ii lp usd nanananana sprott capital lp usd  sprott offshore fund usd sprott offshore fund ii usdnanananana sprott opportunities capital lpnana sprott opportunities offshore fund ltdnana steelhead navigator fund lp sterling oak partnersnana stewart asia fund syw lpnana thames river kingsway plus fund a eurnana thames river kingsway plus fund b usdnana thames river kingsway plus fund c gbpnana the apogee fund lp the bliss fund lpna the decathlon fundna the diamond age russia fundna the leisure fund lp the lobster fund the rader fund lp the tail wind fund ltd the tantallon non usd feeder fund series ana the tantallon non usd feeder fund series bnanananana the tantallon fund lp us feederna the tantallon japan non us feeder fundnanananana the tantallon smaller comp non us feed fundnana the vn capital fund i lp third avenue global value offshore fund third avenue global value fund lp thunder energy partners lp thunder gold partners lp thunder partners lp transamerica longshort fund lpnana trf master fund cayman lpnana triumph fund triumph fund ii lp trophy fund tryphon capital management llc tt asian opportunities fundnanananana tt financials longshort fund usdnana tt longshort europe fund usdna tt longshort japan fund usdna turn of the tide lp ufg russia alternative fundnana ufg russia select fund class a ufg russia select fund class bnana victory capital volteq ged long short equity fund class anana voyage balanced fund ltd class ana wec partners lp wegelin gue alternative alpha fundnana wessex global water fund limited class anana wessex global water fund limited class bnana wessex natural resource fund  class anana wessex natural resource fund  class bna westpark capital lp wilson partners lp ya global investments us lp zacks long short strategyna zar global markets fund lpnana zeff capital offshore fundna zipangu zs crossover ii lp zulauf europe fund euro ltd zulauf europe fund usd ltd equity market neutral casam cisdm equity market neutral indexna aletheia insider index lp alpha equity leveraged market neutral fund alpha equity market plus fund lp alpha strategies fundnana alphastream us small cap eq mark neutralna anaxis sabre style arbitrage fund  eurnana anaxis sabre style arbitrage fund  usdnana ascend market neutral fund lp ascend market neutral fund ltdna cedar street market neutral fundnana cedar street offshore market neutralnanananana concordia capital class f european emn connective capital i offshore fund ltdna connective capital i qp lpnana dafna lifescience market neutral ltd durban capital lp fox run alpha fund lp glc gestalt europe fund ltd hamton us hedge limited hcm market neutral fund lp class ana hcm offshore market neutral fund ltd class ana henderson paneuropean eq multistr fund eurona iiu equity market neutral fund class a usdnanananana iiu equity market neutral fund class b eurnanananana intercept capitalna kassirer market neutral lpna kbd capital partners lp class cnanananana krema absolute return fund llcnana lacm split strike conversion share class a lacm split strike conversion share class a luxembourg investment  us equity plus a usdnana luxembourg investment  us equity plus b eurnana luxembourg investment  us equity plus c usdnana luxembourg investment  us equity plus d eurnana mariner fund euro class  mariner fund euro class  mariner fund usd class  mariner fund usd class  nbc lotus total return banking productna pegasus investment partners lp pegasus market neutral fund lpnana polar capital uk fund ltd euro polar capital uk fund ltd gbp polar capital uk fund ltd usd redstarscom statistical arbitrage fund ltdnana rkc matador market neutral fund llcnana salus market neutral equitized strategy comp salus market neutral strategy composite scivest conservative market neutral fund scivest market neutral equity fund shooter  fianana sollucet partners lpna striker  fim lpnana thames river high income fund usd the cassiopeia fund class b usdna the cassiopeia fund class c eurna the cassiopeia fund class d chfna the mistral fundna the zar equity market neutral fund lpnanananana thinkstrategy capital fund lp thor optima fund lpnana thor optima fund ltd class ana thor optima fund ltd class bnanananana zacks market neutral leveraged event driven multi strategy casam cisdm event driven multistrategy indexna adi situations specialesnana alexandra global investmen fund i ltd usd g alexandra global investment fund i ltd a andromeda global credit fund aspen creek fund ltdna austral opportunities fund ana austral opportunities fund usnana brookline avenue domestic fund lp  share anana copernico special situations fundnana dexia index arbitragena dexia money  risk arbitrage diamond a partners dkr saturn event driven programnana ecf value fund ecf value fund iina ecf value fund intl fortune european small cap eur classnana frontfour lpnana frontfour ltdnana g  rosseau special situations fundnana g  rosseau special situations fund usnana gabelli performance partners gabelli international limited class a gamco performance partners lp haidar neptune fund llcna haidar neptune fund ltdna havens international enhanced investors ltdnana havens international investors ltd havens partners enhanced fund lpnana havens partners lp ibs opportunity fund bvi ltd ibs turnaround fund qpna ibs turnaround fund lp ks capital partners lp ks international litespeed offshore fund ltd litespeed partners lp mm  e capital takeover target fundnana mm  e event driven offshore fundnana mm  e investment trust no mm  e investment trust nona moneda absolute return fund ltdnana moneda retorno absolutonana mq special events fundna natixis european eventsna owl creek asia fund ltdnana owl creek asia i lpnana owl creek asia ii lpnana owl creek i lp owl creek ii lp owl creek overseas fund ltd post total return fund lp post total return offshore fund ltdna rab cross europe fund class a usd rab cross europe fund class b usd rab cross europe fund class c eur rab cross europe fund class e eur rosseau limited partnership sm ls lp the ozone fundna third avenue special situations fund lp third avenue special situations offshore fund twin offshore ltd twin securities lp valens offshore fundnana valens us fund llcnana vision opportunity capital partners lpna vision opportunity capital partners ltdna fixed income abn amro currency fund eurna ais balanced fund lp net alternative treasury strategy llcna alternative treasury strategy ltdna ark discovery fund offshore ltdnanananana ark discovery fund ii lpnanananana blackrock fixed income global opport offshorena blackrock fixed income global opportunitiesna chariot stable asset fund lpna consulta high yield fund pcc euro accum cellna consulta high yield fund pcc usd cell cypresstree alternative income fund eur cypresstree alternative income fund gbp cypresstree alternative income fund usd dexia high yield bb f  c tourmaline fund eurnana f  c tourmaline fund gbpnana f  c tourmaline fund usdnana hamton i  bond  limited hedgeyield limited hedgeyield henderson global fixed inc abs ret ltd eur henderson global fixed inc abs ret ltd usd henderson global fixed inc abs return gbpnana julius baer divers fixed inc h fund gbp ana julius baer diversified fixed income eur cl a julius baer diversified fixed income eur cl b julius baer diversified fixed income usd cl a julius baer diversified fixed income usd cl b mercury international fund macro hedge mgh investment fund ltd pacificor high yield post leveraged loan fund lpnana post strategic fund ii lp rab european credit opportunities b usd rimrock high income plus cayman fund ltdna rimrock high income plus fund lpna rimrock low volatility cayman fund ltdnana rimrock low volatility fund lpnana rivoli long short bond fund sheraton partners lpna thames river sterling global bond fund eurna thames river sterling global bond fund gbpna thames river sterling global bond fund usdna thames river sterling global bond gbp accumna the catpricorn fundna veritas hy short only fund bermuda ltdna waterfall eden fund lpna waterfall eden fund ltdnana weavering fixed income fund ltdna zazove global convertible fund lp fixed income arbitrage casam cisdm fixed income arbitrage indexna alphabridge fixed income fund ltd alphabridge fixed income partners lp asa tax advantage relative value fund lp asa taxable relative value fund ltd asgard fixed income fund i ltd coast enhanced income fund ii coast value fund i ltd concordia capital class c g fixed inc arb concordia capital class n g fi arb x levna concordia municipal opportunites fundna concordia municipal opportunities series iiinana cura fixed income arbitrage fund ltdna dexia bonds euro high yield c dexia bonds euro high yield inana dexia bonds euro high yield nnana dexia bonds global high yield cnana dexia bonds global high yield ina dexia bonds global high yield nnana dexia money  getec dmr structured arbitrage master fundna emf fixed income fund ltd endeavor fund i llc feeder glacier peak tbill arbitrage offshore fundnana group g international ltdna group g investments lp iii fund lp iii fund ltd iii global ltd iii onshore lp iii relative value credit strat fund lp nana iii relative value credit strategies fundnana iii relative valuemacro fund lp iii relative valuemacro fund ltd kallista credit arbitrage fund euro kwk partners lp magnum yield curve opportunity fundna man barnegat fund md sass municipal arbitrage fund llcna mkp opportunity lp mkp opportunity ltd newgate altern inv pall mall abs ret fundna rab european credit opportunities c eur rab european credit opportunities d usd rab european credit opportunities e eur rab european loan fund class a eurna rab european loan fund class b usdna rab european loan fund class c eurna rab european loan fund class d usdna rab european loan fund class p gbpnana rab european loan fund class q gbpnana the galaxite fundna the galaxite fund offshorena the obsidian fund the obsidian fund offshore tiden destiny fund ltdnana ufg russia debt fundna fixed income mbs cisdm mortgage backed securities indexna adhia arbitrage fund lp epargne mbs plus strategy ana epargne mbs plus strategy bnanananana euribor plus strategy share ona hfh shortplus fund ltdnana hfh shortplus lpnana kevlon fund lp mbs fund caspian share r mbs fund caspian share rnana mbs fund gamma share o midway market neutral fund domestic class b midway market neutral intern fund offshore b mkp credit lp mkp credit ltd mkp partners lp mkp partners ltd rushmore capital partners llcnana the goldstein capital managed bond portfolio the lynx fund i lp global macro casam cisdm global macro indexna abraxas fund limited absolute macro diversified fund gbpnanananana absolute macro diversified fund usdnana ais taap composite argonaut aggressive global partnership lp argonaut global macro fund ltdnana balestra capital partners lp banyan capital fund lpna biam alpha strategies bond fund i class a usdnanananana biam alpha strategies currency fund i a usdnanananana blue sky world lpnana btr global macro fundna bwii lpnana clarium lp crescat global macro fund lpnana foyil focused strategy fund individual foyil focused strategy fund institutionalnana friedberg global macrohedge fund ltd friedberg total return fixed income fund ltd global undervalued securities fund graham capital discretionary portfoliona graham capital fed policy portfolio haidar jupiter international ltd harmonic global fund macro ii highlander partners usa lp integra investment management lp jaguar commodity fund limitedna jb global rates hedge fund chfna jb global rates hedge fund eurna jb global rates hedge fund gbpna jb global rates hedge fund usdna jb global rates hedge fund llcnana kohinoor series two fundnana lacm macro discretionary share class f lyford fund x maxq fund limited eur maxq fund limited usd mkp global futures lpnana mlm macro  peak partners lp mlm macro  peak partners offshore fund ltd mlm macro  peak select partners lpna multi asset platform conservative fundnana multi asset platform moderate fundnana multi asset platform plus fundnana nbc glob macro total return bank product usdnana nbc macrorisk total return banking productna pharo alpha fund ltdnana pharo macro fund ltdna polar capital discovery fund ltd eurnana polar capital discovery fund ltd gbpnana polar capital discovery fund ltd usdnana ponta negra fund i llcnana portage fund ltdna portage partners lpna quantedge global fundnana rg niederhoffer global fund lp i rg niederhoffer negative correlation fund ltdna rg niederhoffer optimal alpha fund ltdna ronin master op investors ltd roy g niederhoffer fund ireland  roy g niederhoffer fund ireland  roy g niederhoffer trendhedge fund ltdna shearwater fund chfnana tack fund lp fx tanager fundnana the capital hedge fund ltd the capital trading fund ltdnana wexford offshore spectrum fund class a windmill partners lp market timing edgewood partners l p merger arbitrage casam cisdm merger arbitrage indexna austral equity fund  coastview equity partners lpna dexia long short risk arbitrage dkr ibex fund ltd gabelli associates fundnana gabelli associates limited glazer capital management lp glazer offshore fund ltd hudson valley partners lpna the anvil fund ltd the merger fund ltd washburne capital management lp washburne capital offshore ltd weaver arbitrage partners multi strategy absolute trading  fundna aims low volatility fund  eur class share aims low volatility fund  usd class fund aims medium volatility fund  eur class share aims medium volatility fund  usd class share aleo absolute return fundna argentum multistrategy fund llcnana arx brazil fund spc  multistrategy classnana ascend alpha strategies fund lpnana ascend alpha strategies ltdnana ascendant global strategies fundnanananana attalus enhanced lehman aggregate index fund attalus enhanced russell  index fund attalus enhanced s  p  index fund auda opportunities ltd babylon fundnana bluefin enhanc money mrkt fnd segr portf bna branzan alternative opportunities fund llpnana btr global arbitrage fund chinook fund llc concordia asiapacific multistrategy fundnana delaware street capital ii lp delaware street capital offshore ltd delaware street capital lp dendrich fund lpnana dexia glob world absol perform funds eur c dexia glob world absol perform funds eur inana dexia global world abs perform funds usd inanananana dexia global world abs perform funds chf cnana dexia global world absolute performance usd cnana dexia money  credit spread dexia money  multistrategies dexia money  opportunistic strategies dkr fusion fund ltdna dynamic preservation fund lpnana edgebrook partners lpna eurasian frontiers fundnana everyoung growth fundnana ferrell arc fundnana fmg middle east north africa fund a euronana fmg middle east north africa fund a usdnana fmg middle east north africa fund b euronana fmg middle east north africa fund b usdnana fortune compass fundna globersel bcm multi asset classnana gondwana fund eur class gondwana fund usd class graham capital proprietary matrix portfolio h japan fundnana henderson asia pacif equity multistr fundnana henderson glob equity multistrat fund audnanananana henderson global equity multistrategy eurnana henderson global equity multistrategy gpbnana henderson global equity multistrategy usdnana henderson n a equity multistrategy ltd usdna henderson paneuro equity multistr ltd usdna iiu convertible fund class a usd lacm legacy share class c lee enhanced offshore fund ltdnana lim asia arbitrage fund magic capital fund lpna magnum secured debt fundnana mellon recovery fund class bnana metage global strategies i metage global strategies ii metage global strategies iiina mg secured debt fundnana northstar fund ii lp northstar fund iii lp northstar fund iv ltd novy fund eurnana novy fund usdnana odey tactical advantage eurnana odey tactical advantage usdnana oneworld bric opportunity fund i class a llcnana osmium special situations fund ltdna polar capital elbrus fund ltd usdnana qbasis futures fundnanananana rab northwest china opportunities fund usdna rab northwest fund class a usd rab northwest fund class b eur rab northwest japan fund class jpy rab northwest japan fund class usdna rab northwest warrant fund usd classnana reichmuth hochalpinna rgt onshore fund llcna rkc matador fund llcnana sextant strategic opportunities hedge fund lpnana shepherd investments international ltd singleton fund llcnana sirocco fund llc stark investments limited partnership sunnymeath partnersnana talkot fund lp the horizon fund upper left quadrant fundnana upper middle quadrant fundnana upper right quadrant fundnana ventura capital partners llcnana voyage premium fund ltd class b watchmaker diversified fundna wegelin gue active currencies fund eurnana wexford spectrum fund lp class a zar multi strategy fund lpnanananana zazove aggressive growth fund lp option arbitrage aspen private capital partners i lpnana cc athena os fund ltd euro retail sub classna cc athena os fund ltd euro inst sub classna cc athena os fund ltd usdnana coastwise premium appreciation fund lpna crosscourt partners lpnanananana f  c sapphire fundna hyman beck volatility analyticsnana innovative options fund lp innovative options offshore ltdna kulshan capital fund lpna mm capital select fund lpnana parallax fund lp parallax fund ltdnanananana rosen capital institutional lpnanananana rosen capital partners rosen offshore limited snow fund one llcnana titan asia volatility fund ltd titan global relative value volatility fund titan global return fund lp titan global volatility fund  class mnana titan relative value volatility fund lp titan volatility fund lp us voyage balanced fund class bnana voyage optima fund ltdnana other relative value dexia credit arbitragena dexia money  double alpha dkr quantitative strategies x programnana h global commodities fundnana iig trade opportunities fund nv ilex european leveraged loan fund eur bnana ilex european leveraged loan fund eur cnanananana ilex european leveraged loan fund usd bnana jem commodity relative value programnana kbd capital partners lp class a kbd capital partners lpclass bnana kbd capital partners ltd class bnana relative value arbitrage line class anana rivernorth capital partners lpnanananana the deva  alpha fundnana the sweet spot fund regulation d asa opportunity fund lpna relative value multi strategy aria partners ii lpna branzan alternative investment fund lp concordia capital class a multistrategy dexia volatility opportunitiesnana dkr international relative value x programnana dkr international relative value fund ltd dkr international relative value ltd class b excelsior investors ltd excelsior partners lp iceberg alternative real estate fund masternana ilex credit fund eur class ilex credit fund usd class lazard rathmore fund ltdnanananana platinum partners value arb intl limited platinum partners value arb fund usa lp rittenhouse hedged equity portfolio lpna sector casam cisdm sector indexna abernathy group value trust lpna acadia fund i lp advisory research energy fund lpna alpha praedium  fund alpha praedium market neutral fund alphagen rhocas class a usdna alphagen rhocas class b eurona berkshire partnership blackrock agriculture fundnanananana blackrock allcap energy hedge fundna blackrock allcap energy hedge fund offshorena blackrock smallcap energy hedge fund cambridge energy lp canterbury growth fund caritas royalties fund bermuda ltdna caritas royalties fund ii bermuda ltdnana caritas royalty fund ii llcnana caritas royalty fund llcna consulta canadian energy fund limited consulta canadian oil  gas fund bvnana consulta canadian oil sands fund bvnana cypresstree leveraged alternative income eurna cypresstree leveraged alternative income usdna dafna lifescience ltd dafna lifescience select ltdna dorset energy fund limited drake associates dynamis energy fund lp dynamis energy fund ltdna ecofin global utilities hedge fund ltdna elco energy fund lp elco select fund lp financial edge fund lp financial stocks lp foundation financial partners llc galleon omni communications fund galleon omni technology fund series a gazinvest fundna gerbino gold group llc global advisors commodity systematic bnana global advisors commodity systematic ltdna global energy value fund chfna global energy value fund eurna global energy value fund usdna guinness energy fundnana hangar  eagle i lp harvest technology partnersnana highview avenue energy fund ltdnana hornet renewable energy fundnana junior energy fundnana jupiter hyde park hedge fund eur classnana jupiter hyde park hedge fund gbp classnana l  s partners i llc lucas energy total return offshore cna lucas energy total return partners ii lpnana lucas energy total return partners lp marathon resource partners i lp marathon resource partners iiinana martin currie arf  global resources fund eurna martin currie arf  global resources fund usdna mayer partners lpnana mcomber energy fundna mendon capital llc moors and mendon offshore fund new russian generation limitednanananana oracle global healthcare lpna perceptive life sciences fund lp perceptive life sciences offshore fund ltd perceptive life sciences qualified fund lp perennial growth fund limitedna pharmainvest fundnana polar capital glob util abs ret fund eurnana polar capital glob util abs ret fund gbpnana polar capital glob util abs ret fund usdnana rab energy fund class a eurna rab energy fund class b usdna rab energy fund class c eurna rab energy fund class d usdna rab energy fund class e eurnana rab energy fund class f usdnana rab octane fund class c eurna rab octane fund class d usdna scivest oil sands index plus fundnana short credit fund class a  initial seriesnanananana short credit fund lpnanananana sigma investment trust plc sterlingnana sophrosyne technology fund ltdnana spinner global technology fund sprott strategic gold fund lpna sprott strategic offshore gold fund ltdna sunbeam opportunities fund master thames river prop growth income fund eurona thames river prop growth income fund gbpna thames river proper growth  income fund noknana thames river property growth income fund audnana thames river property growth  income audnana thames river property growth  income gbpna thames river property growth  income fund eurona the abernathy group growth trust lp the water fundna the water fund exna third avenue real estate opport fund lpnana thunder silver partners lpna tocqueville gold offshore fund ltd tocqueville gold partners lpnana tryphon fund inc visium balanced fund lpnana visium balanced offshore fund ltdnana visium long bias fund lpnana visium long bias offshore fund ltdnana wessex gold fund class ananananana wessex gold fund class bnanananana wexford catalyst fund lpna wexford offshore catalyst fund limitedna short bias arcas fund ii covered interests arcas fund ii lp arcas interests arcas international fund covered interests arcas international fund ltd arcas interests connective capital ii qp lpnana ham short biased fundnana leveraged short equity index hedge lp leveraged short equity index hedge ltd reynard american partners lp reynard international partners ltd scivest global net short equity fundnana tuckerbrook short alpha compositenanananana waterloo international fund ltdna waterloo partners lp single strategy absolute guaranteed fx  aud evolution classnana absolute guaranteed fx  gbp classnana absolute guaranteed fx  gbp evolution classnana absolute guaranteed fx  usd classnana absolute guaranteed fx  usd evolution classnana alegra abs i euro fundna alegra abs two euro fundnana ambit bridge loan fund i llcnana ambit bridge loan fund international i ltdnana ark royal fund offshore limitedna asian reit property fund  eur classnana asian reit property fund  gbp classnana asian reit property fund  usd classnana barington companies equity partners lp belmont enhanced treasuries fund lp belmont enhanced treasuries fund ltd broadmark futures fund ltdnana denholm hall russia arbitrage fund  a shares denholm hall russia arbitrage fund  b sharesna denholm hall russia arbitrage fund  c sharesnana dexia global event fundnana dexia leveraged loansnana european opportunities hedge fundnana genesis merchant partners lpnanananana genus dynamic mining fund d usdnana genus dynamic mining fund u eurnana ggcp emerald bay international ltdnana ggcp emerald bay investments lpnana harvest small cap partners strategynana jb curr hedge fund discr segreg portfolionana jericho allweather opportunity fund lpnana kaizen fundamental value fund natural resources hedge fundna oei mac inc gbp ana oei mac inc gbp bnanananana oei mac inc usd pavlik capital partners llcnanananana prana limited ltdna rab diversified commodities fund eurnana rab diversified commodities fund usdnana rab gold fund class a eurnana rab gold fund class b usdnana rab gold fund class c eurnana rab gold fund class d usdnana rab gold fund gold share class usdnana rab innovations fund ltd class a eurnana rab innovations fund ltd class b usdnana regent fund spcnanananana rhicon strategic fund  currency programna rk invest advisors alpha enhanced indexnana uk emerging companies hedge fundna uk equity hedge fundna veritas credit opportunities fund llcnana veritas credit opportunities fund ltdnana zar currency insight fund lpnana back to market lab index     barrons market lab table  barronscom return to top return to top customer service customer center contact us create an account subscribe to barrons magazine subscribersactivate your digital access about barronscom why subscribe advertising masthead privacy policy cookie policy data policy copyright policy subscriber agreement terms of use your ad choices community guidelines also from barrons conferences reprints classifieds college program find a broker barrons in japanese tools  services mobile site email newsletters barrons on ipadiphone portfolio old portfolio video stockgrader barrons  economic calendar stock  mutual fund listings commodities options annuities listings copyright   dow jones  company inc all rights reserved